CN1580058A - Method for preparig 3-chloromethyl-3-cephem derivative crystalline - Google Patents
Method for preparig 3-chloromethyl-3-cephem derivative crystalline Download PDFInfo
- Publication number
- CN1580058A CN1580058A CN 03149608 CN03149608A CN1580058A CN 1580058 A CN1580058 A CN 1580058A CN 03149608 CN03149608 CN 03149608 CN 03149608 A CN03149608 A CN 03149608A CN 1580058 A CN1580058 A CN 1580058A
- Authority
- CN
- China
- Prior art keywords
- solution
- chloromethyl
- derivative
- reaction
- cephem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
本发明提供一种不间断反应就能以高收率、高纯度制造3-氯甲基-3-头孢烯衍生物结晶的方法。通式(2)表示的3-氯甲基-3-头孢烯衍生物结晶的制造方法是在含有醇和醚的溶剂中、在pH为8以下的条件下,使通式(1)表示的氯化吖丁啶酮衍生物和醇盐进行反应,(式中,R1表示取代或未取代的芳基、或者取代或未取代的杂环残基,R2和R3表示取代或未取代的芳香族烃基)。
The invention provides a method for producing 3-chloromethyl-3-cephem derivative crystals with high yield and high purity without interrupting the reaction. The production method of the 3-chloromethyl-3-cephem derivative crystal represented by general formula (2) is to make chlorine represented by general formula (1) Piazetidinone derivatives and alkoxides are reacted, (wherein, R 1 represents substituted or unsubstituted aryl, or substituted or unsubstituted heterocyclic residues, R 2 and R 3 represent substituted or unsubstituted aromatic hydrocarbons).
Description
技术领域technical field
本发明涉及3-氯甲基-3-头孢烯衍生物结晶的制造方法,特别涉及能够得到可用作3-氯甲基-3-头孢烯系各种抗菌素的合成中间体的、以下述通式(2)表示的3-氯甲基-3-头孢烯衍生物结晶的制造方法。The present invention relates to the manufacture method of 3-chloromethyl-3-cephem derivative crystal, particularly relate to can obtain and can be used as the synthetic intermediate of various antibiotics of 3-chloromethyl-3-cephem, with following general A method for producing crystals of 3-chloromethyl-3-cephem derivatives represented by formula (2).
(式中,R2、R3表示取代的或未取代的芳香族烃基)。(wherein, R 2 and R 3 represent substituted or unsubstituted aromatic hydrocarbon groups).
背景技术Background technique
已知由上述通式(2)表示的3-氯甲基-3-头孢烯衍生物是一种可用作合成头孢菌素类抗菌素的合成中间体的化合物(特开昭59-172493号公报、特开昭58-72591号公报、特开昭60-255796号公报、特开昭61-5084号公报、特开平1-156984号公报、特开平1-308287号公报、国际公开号WO99/10352号公报、国际公开号WO98/58932号公报等)。It is known that the 3-chloromethyl-3-cephem derivative represented by the above-mentioned general formula (2) is a compound that can be used as a synthetic intermediate for the synthesis of cephalosporins (Japanese Patent Laid-Open No. 59-172493 , JP-A-58-72591, JP-60-255796, JP-61-5084, JP-1-156984, JP-1-308287, International Publication No. WO99/10352 Publication No., International Publication No. WO98/58932, etc.).
过去,以上述通式(2)表示的3-氯甲基-3-头孢烯衍生物的制造方法,例如,提出过使3-乙酰氧基甲基头孢菌素衍生物的3位乙酰氧基甲基的乙酰氧基在三氯化硼等Lewis酸存在下进行卤化的方法(Tetradedronlett.,3991p.1974)、将由青霉素G制备的2-吖丁啶酮衍生物经电解反应氯化以后,通过碱处理闭环形成头孢烯衍生物的方法(Tetradedronlett.,23,2187p,1982)的方法、按照如下的反应式(1),In the past, the production method of 3-chloromethyl-3-cephem derivatives represented by the above general formula (2), for example, proposed to make the 3-acetoxy group of 3-acetoxymethyl cephalosporin derivatives The method of halogenating the acetoxy group of the methyl group in the presence of Lewis acids such as boron trichloride (Tetradedronlett., 3991p.1974), after the 2-azetidinone derivative prepared by penicillin G is chlorinated by electrolytic reaction, through The method (Tetradedronlett., 23, 2187p, 1982) of the method (Tetradedronlett., 23, 2187p, 1982) of alkali treatment ring-closing to form cephem derivatives, according to the following reaction formula (1),
反应式(1)Reaction formula (1)
在碱土族金属碳酸盐存在下,将7-取代氨基-3-羟甲基-3-头孢烯-4-羧酸酯(化合物(3))与氯化试剂进行反应的方法(特开平4-66584号公报);按照如下的反应式(2),In the presence of alkaline earth metal carbonates, the method of reacting 7-substituted amino-3-hydroxymethyl-3-cephem-4-carboxylate (compound (3)) with a chlorination reagent (Japanese Patent Application No. 4 -66584 bulletin); according to the following reaction formula (2),
在碱存在下,使吖丁啶酮衍生物(化合物(1a))在有机溶剂中进行反应的方法(特开昭58-74689号公报)。A method of reacting an azetidinone derivative (compound (1a)) in an organic solvent in the presence of a base (JP-A-58-74689).
其中,特开昭58-74689号公报是制造油状3-氯甲基-3-头孢烯衍生物的方法,该方法是将原料吖丁啶酮衍生物(化合物(1a))与反应生成物3-氯甲基-3-头孢烯衍生物一起溶解于用作反应溶剂的N,N-二甲基甲酰胺中,将弱碱性的氨或者氨水用作碱,在防止反应生成物分解的同时进行反应,得到油状的3-氯甲基-3-头孢烯衍生物的方法。Among them, Japanese Unexamined Patent Publication No. 58-74689 is a method for producing oily 3-chloromethyl-3-cephem derivatives. The method is to mix the raw material azetidinone derivative (compound (1a)) with the reaction product 3 -Chloromethyl-3-cephem derivatives are dissolved together in N,N-dimethylformamide used as a reaction solvent, and weakly basic ammonia or ammonia water is used as a base to prevent the reaction product from decomposing A method of carrying out the reaction to obtain an oily 3-chloromethyl-3-cephem derivative.
另外,在特开昭58-74689号公报中,作为反应溶剂可以举出甲醇、乙醇、异丙醇等醇,作为碱可以举出强碱性的氢氧化钠、氢氧化钾等金属氢氧化物,但由于醇不能溶解作为反应生成物的3-氯甲基-3-头孢烯衍生物,因而不能得到油状物,而且由于如果这些醇和碱反应生成水,使此水中溶有碱,从而使反应体系的pH值升高呈碱性,就会使反应生成物3-氯甲基-3-头孢烯衍生物分解,从而降低了收率。In addition, in JP-A-58-74689, examples of reaction solvents include alcohols such as methanol, ethanol, and isopropanol, and examples of bases include highly basic metal hydroxides such as sodium hydroxide and potassium hydroxide. , but because the alcohol cannot dissolve the 3-chloromethyl-3-cephem derivative as the reaction product, an oily product cannot be obtained, and because if these alcohols react with the alkali to generate water, the alkali is dissolved in the water, thereby making the reaction When the pH value of the system increases and becomes alkaline, the reaction product 3-chloromethyl-3-cephem derivative will be decomposed, thereby reducing the yield.
并且,由于在3-氯甲基-3-头孢烯衍生物的分子中有反应活性很高的氯原子,在油状物的状态下不稳定,例如在室温下保存时会释放出盐酸而促进自分解,导致品质降低,因此人们希望能得到在温和的条件下具有较长时间稳定性的产物。And, because there is very reactive chlorine atom in the molecule of 3-chloromethyl-3-cephem derivative, it is unstable in the state of oil, for example, hydrochloric acid will be released to promote self-dissolution when preserved at room temperature. Decomposition, resulting in reduced quality, so people hope to obtain products with longer time stability under mild conditions.
因此,就提出了从油状物制成结晶得到3-氯甲基-3-头孢烯衍生物的方法。Therefore, a method for crystallizing 3-chloromethyl-3-cephem derivatives from oils has been proposed.
例如,在国际公开号WO99/10352号公报中,提出了一种使3-氯甲基-3-头孢烯衍生物的油状物的N,N-二甲基甲酰胺溶液在冷却的醇或醇·水中结晶析出,得到3-氯甲基-3-头孢烯衍生物的结晶物的方法。For example, in International Publication No. WO99/10352, it is proposed to make the N, N-dimethylformamide solution of the oil of 3-chloromethyl-3-cephem derivatives in cooled alcohol or alcohol - A method for obtaining crystals of 3-chloromethyl-3-cephem derivatives by crystallization in water.
但是,根据WO99/10352号公报,一旦合成了3-氯甲基-3-头孢烯衍生物的油状物,必须再经过结晶析出这样的复杂工序,不利于工业生产。However, according to WO99/10352, once the oily substance of 3-chloromethyl-3-cephem derivatives is synthesized, it must go through complicated procedures such as crystallization, which is unfavorable for industrial production.
发明内容Contents of the invention
因此,本发明的目的是提供一种能通过反应连续地以高收率和高纯度得到可用作头孢菌素系的各种抗菌素合成中间体的3-氯甲基-3-头孢烯衍生物的结晶的、有利于工业生产的3-氯甲基-3-头孢烯衍生物结晶的制造方法。Therefore, the object of the present invention is to provide a kind of 3-chloromethyl-3-cephem derivatives that can be used as various antibiotic synthetic intermediates of cephalosporin series with high yield and high purity continuously by reaction Crystallized, industrially beneficial 3-chloromethyl-3-cephem derivative crystals.
鉴于上述的课题,本发明人等对通过反应不间断地得到3-氯甲基-3-头孢烯衍生物结晶的方法进行锐意研究的累积结果,发现了原料氯化吖丁啶酮衍生物和醇的组合,而且发现了不会溶解3-氯甲基-3-头孢烯衍生物结晶的醇和可溶解原料氯化吖丁啶酮衍生物和反应副产物杂质的醚的组合,以作为反应溶剂。按照该反应体系,如果在无水状态下,在特定范围的pH值下控制反应的进行,就能够通过反应,不间断地高收率且高纯度地得到由上述通式(2)表示的作为目的物的3-氯甲基-3-头孢烯衍生物结晶,从而完成本发明。In view of the above-mentioned problems, the inventors of the present invention have intensively studied a method for continuously obtaining crystals of 3-chloromethyl-3-cephem derivatives by reaction, and found that the raw materials of azetidinone chloride derivatives and A combination of alcohols, and a combination of an alcohol that does not dissolve the crystals of 3-chloromethyl-3-cephem derivatives and an ether that can dissolve the raw material chlorinated azetidinone derivatives and the impurities of the reaction by-products was found to be used as a reaction solvent . According to this reaction system, if the progress of the reaction is controlled at a pH value in a specific range in an anhydrous state, the product represented by the above general formula (2) can be obtained in high yield and high purity without interruption through the reaction. The object 3-chloromethyl-3-cephem derivative was crystallized, thereby completing the present invention.
即,本发明是如下述通式(2)所示的3-氯甲基-3-头孢烯衍生物结晶的制造方法,其特征在于,在含醇溶剂中、pH为8以下的条件下,使如下述通式(1)That is, the present invention is a method for producing 3-chloromethyl-3-cephem derivative crystals represented by the following general formula (2), characterized in that, in an alcohol-containing solvent at a pH of 8 or less, Make the following general formula (1)
(式中,R1表示取代或未取代的芳基、或者取代或未取代的杂环残基,R2和R3表示取代或未取代的芳香族烃基。)(In the formula, R 1 represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic residue, and R 2 and R 3 represent a substituted or unsubstituted aromatic hydrocarbon group.)
(式中,R2和R3表示取代或未取代的芳香族烃基。)(In the formula, R 2 and R 3 represent substituted or unsubstituted aromatic hydrocarbon groups.)
所示的氯化吖丁啶酮衍生物和醇盐进行反应。The indicated chloride azetidinone derivatives are reacted with alkoxides.
并且,本发明提供了一种如下述通式(2)所示的3-氯甲基-3-头孢烯衍生物结晶的制造方法,其特征在于,在含醇和醚的溶剂中、pH值为8以下的条件下,使如下述通式(1)所示的氯化吖丁啶酮衍生物和醇盐进行反应。And, the present invention provides a kind of manufacture method of 3-chloromethyl-3-cephem derivative crystal as shown in following general formula (2), it is characterized in that, in the solvent containing alcohol and ether, pH value is Under the condition of 8 or less, the azetidinone chloride derivative represented by the following general formula (1) and the alkoxide were reacted.
(式中,R1表示取代或未取代的芳基、或者取代或未取代的杂环残基,R2和R3表示取代或未取代的芳香族烃基);(wherein, R 1 represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic residue, R 2 and R 3 represent a substituted or unsubstituted aromatic hydrocarbon group);
(式中,R2和R3表示取代或未取代的芳香族烃基)。(wherein, R 2 and R 3 represent substituted or unsubstituted aromatic hydrocarbon groups).
在本发明中,优选为将溶解在含醚溶剂中的上述氯化吖丁啶酮衍生物溶液(A)、和溶解在含醇溶剂中的醇盐溶液(B),加入含醇溶液(C)中进行反应。In the present invention, it is preferable to add the above-mentioned chlorinated azetidinone derivative solution (A) dissolved in an ether-containing solvent and the alkoxide solution (B) dissolved in an alcohol-containing solvent to the alcohol-containing solution (C ) for the reaction.
优选在上述含醇溶液(C)中,加入作为溶解在含醚溶剂中的氯化吖丁啶酮衍生物溶液(A)的一部分的、含有反应当量为5~30mol%的氯化吖丁啶酮衍生物溶液(A)之后,将其余的含有氯化吖丁啶酮衍生物的溶液(A)与溶解在含醇溶剂中的醇盐溶液(B)同时加入到上述含醇溶液(C)中进行反应。Preferably, in the above-mentioned alcohol-containing solution (C), an azetidine chloride containing 5 to 30 mol% of reaction equivalent is added as a part of the azetidinone chloride derivative solution (A) dissolved in an ether-containing solvent. After the ketone derivative solution (A), the remaining solution (A) containing the chlorinated azetidinone derivative and the alkoxide solution (B) dissolved in the alcohol-containing solvent are simultaneously added to the above-mentioned alcohol-containing solution (C) react in.
上述氯化吖丁啶酮衍生物和醇盐的反应,优选为以1mol的氯化吖丁啶酮衍生物对0.8~1.5mol醇盐的比例进行反应。The above-mentioned reaction of the chlorinated azetidinone derivative and the alkoxide is preferably carried out at a ratio of 1 mol of the chlorinated azetidinone derivative to 0.8 to 1.5 mol of the alkoxide.
上述醇优选为,选自甲醇或乙醇中的至少一种。The aforementioned alcohol is preferably at least one selected from methanol or ethanol.
上述醚优选为二噁烷。The aforementioned ether is preferably dioxane.
上述醇盐优选为甲醇钠或乙醇钠。The aforementioned alkoxide is preferably sodium methoxide or sodium ethoxide.
上述反应优选在5℃以下进行。The above reaction is preferably carried out at below 5°C.
上述含有氯化吖丁啶酮衍生物的溶液(A)优选为将氯化吖丁啶酮衍生物溶解于二噁烷或醇中而成的溶液。The solution (A) containing the azetidinone chloride derivative is preferably a solution obtained by dissolving the azetidinone derivative in dioxane or alcohol.
上述含有醇盐的溶液(B)优选为将醇盐溶于醇而成的溶液。The above-mentioned alkoxide-containing solution (B) is preferably a solution obtained by dissolving alkoxide in alcohol.
上述含醇溶液(C)优选为醇和二噁烷的混合溶剂。The aforementioned alcohol-containing solution (C) is preferably a mixed solvent of alcohol and dioxane.
优选为通过滴加来添加上述溶液(A)和溶液(B)以进行反应。It is preferable to add the above-mentioned solution (A) and solution (B) by dropwise addition to react.
上述反应优选为在无水状态下进行。The above reaction is preferably carried out in an anhydrous state.
具体实施方式Detailed ways
下面详细地说明本发明。The present invention will be described in detail below.
本发明提供如下述通式(2)所示的3-氯甲基-3-头孢烯衍生物结晶的制造方法,其特征在于,将溶解于含醚溶剂中的如下述通式(1)所示的氯化吖丁啶酮衍生物溶液(A)(下面记作“含有氯化吖丁啶酮衍生物的溶液(A)”);和溶解于含醇溶剂中的醇盐溶液(B)(下面记作“含有醇盐的溶液(B)”)滴加到含醇溶液(C)中,在pH为8以下的条件下进行反应。The present invention provides a method for producing crystals of 3-chloromethyl-3-cephem derivatives represented by the following general formula (2), characterized in that, dissolving in ether-containing solvents as represented by the following general formula (1) A chlorinated azetidinone derivative solution (A) (hereinafter referred to as "chlorinated azetidinone derivative-containing solution (A)"); and an alkoxide solution (B) dissolved in an alcohol-containing solvent (hereinafter referred to as "alcoholate-containing solution (B)") was added dropwise to the alcohol-containing solution (C), and reacted at pH 8 or less.
(式中,R1表示取代或未取代的芳基、或者取代或未取代的杂环残基,R2和R3表示取代或未取代的芳香族烃基。)(In the formula, R 1 represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic residue, and R 2 and R 3 represent a substituted or unsubstituted aromatic hydrocarbon group.)
并且,含有氯化吖丁啶酮衍生物的溶液(A)和含有醇盐的溶液(B)的滴加量,优选为在上述含有氯化吖丁啶酮衍生物的溶液(A)和上述含有醇盐的溶液(B)中,相对于1mol的氯化吖丁啶酮,醇盐的摩尔比为0.8~1.5倍mol。In addition, the dropwise amounts of the solution (A) containing the azetidinone derivative and the solution (B) containing the alkoxide are preferably between the above-mentioned solution (A) containing the azetidinone derivative and the above-mentioned In the solution (B) containing an alkoxide, the molar ratio of an alkoxide is 0.8-1.5 times mol with respect to 1 mol of azetidinone chlorides.
并且,滴加量优选为,在滴加结束时,反应溶剂中醇含量为30~95重量%。In addition, the amount of dropping is preferably such that the alcohol content in the reaction solvent is 30 to 95% by weight at the end of the dropping.
并且,上述反应优选为配制成含有以上述通式(1)表示的氯化吖丁啶酮衍生物的溶液(A),先使氯化吖丁啶酮衍生物的反应当量为5~30mol%地将一部分含有上述氯化吖丁啶酮衍生物的溶液(A)滴加到含醇溶剂中,再将其余的含有以上述通式(1)表示的氯化吖丁啶酮衍生物的溶液(A)与含有醇盐的溶液(B)同时滴加到含醇溶液(C)中地进行反应。And, above-mentioned reaction is preferably to be prepared into the solution (A) that contains the chlorinated azetidinone derivative represented by above-mentioned general formula (1), first make the reaction equivalent of chlorinated azetidinone derivative be 5~30mol% A part of the solution (A) containing the above-mentioned chlorinated azetidinone derivatives is added dropwise to the alcohol-containing solvent, and the rest of the solution containing the chlorinated azetidinone derivatives represented by the above general formula (1) (A) and an alkoxide-containing solution (B) are simultaneously dripped and reacted in alcohol-containing solution (C).
并且,上述含有氯化吖丁啶酮衍生物的溶液(A)优选是由二噁烷和醇的混合溶剂溶解氯化吖丁啶酮衍生物得到的溶液。Furthermore, the solution (A) containing the azetidinone chloride derivative is preferably a solution obtained by dissolving the azetidinone chloride derivative in a mixed solvent of dioxane and alcohol.
而上述含有醇盐的溶液(B)优选是由醇盐溶解于醇而成的溶液。On the other hand, the solution (B) containing an alkoxide is preferably a solution in which an alkoxide is dissolved in alcohol.
并且,上述含醇溶液(C)优选是醇和二噁烷的混合溶剂。Furthermore, the alcohol-containing solution (C) is preferably a mixed solvent of alcohol and dioxane.
下面表示本发明的3-氯甲基-3-头孢烯衍生物结晶制造方法的反应式。The reaction formula of the method for producing crystals of the 3-chloromethyl-3-cephem derivative of the present invention is shown below.
然后说明本发明的制造方法中所用的上述溶液(A)~(C)。Next, the above-mentioned solutions (A) to (C) used in the production method of the present invention will be described.
<含有氯化吖丁啶酮衍生物的溶液(A)><Solution (A) Containing Chlorinated Azetidinone Derivatives>
作为用于本发明的原料的以上述通式(1)表示的氯化吖丁啶酮衍生物(下面也记作“氯化吖丁啶酮衍生物(化合物(1))”)的R1表示取代或未取代的芳基或者取代或未取代的杂环残基。作为芳基,具体可以举出苯基、p-甲基苯基、p-甲氧基苯基、p-硝基苯基、p-氯苯基、五氯苯基等。而作为取代的或未取代的杂环残基,可以举出2-吡啶基、2-苯并噻唑基、1,3,4-噻二唑-5-基、2-甲基-1,3,4-噻二唑-5-基、1,2,3,4-四唑-5-基、1-甲基-1,2,3,4-四唑-5-基、1-苯基-1,2,3,4-四唑-5-基等。 R1 of the chlorinated azetidinone derivative (hereinafter also referred to as "chlorinated azetidinone derivative (compound (1))") represented by the above-mentioned general formula (1) as a raw material used in the present invention represents a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocyclic residue. Specific examples of the aryl group include phenyl, p-methylphenyl, p-methoxyphenyl, p-nitrophenyl, p-chlorophenyl, pentachlorophenyl and the like. As substituted or unsubstituted heterocyclic residues, 2-pyridyl, 2-benzothiazolyl, 1,3,4-thiadiazol-5-yl, 2-methyl-1,3 , 4-thiadiazol-5-yl, 1,2,3,4-tetrazol-5-yl, 1-methyl-1,2,3,4-tetrazol-5-yl, 1-phenyl -1,2,3,4-tetrazol-5-yl and the like.
而R2和R3表示取代的或未取代的芳香族烃基。具体可以举出苄基、p-甲氧基苄基、苯基、p-甲苯基等,R2和R3可以相同,也可以不同。And R 2 and R 3 represent substituted or unsubstituted aromatic hydrocarbon groups. Specific examples include benzyl, p-methoxybenzyl, phenyl, p-tolyl, etc. R2 and R3 may be the same or different.
由上述通式(1)表示的氯化吖丁啶酮衍生物,例如在通式(1)中R2是苄基,R3是p-甲氧基苄基的化合物,可以噻唑啉吖丁啶酮衍生物为原料,由如下所示的反应式(3)和反应式(4)的2步反应来制造(参照特公平5-9425号公报)。Chlorinated azetidinone derivatives represented by the above-mentioned general formula (1), for example, in the general formula (1), R 2 is benzyl, and R 3 is a compound of p-methoxybenzyl, which can be thiazoline azetidine Pyridone derivatives are used as raw materials, and are produced by the two-step reaction of the following reaction formula (3) and reaction formula (4) (refer to Japanese Patent Publication No. 5-9425).
反应式(3)Reaction formula (3)
反应式(4)Reaction formula (4)
(式中,R1与前面具有相同的意义)。(In the formula, R1 has the same meaning as above).
<含有氯化吖丁啶酮衍生物的溶液(A)><Solution (A) Containing Chlorinated Azetidinone Derivatives>
可将按照上述反应式(4)得到的反应生成物氯化吖丁啶酮衍生物溶解于溶剂的溶液经调整后用作本发明的含有氯化吖丁啶酮衍生物的溶液(A)。The solution (A) containing the azetidinone chloride derivative of the present invention can be adjusted by dissolving the reaction product obtained by the reaction formula (4) in which the azetidinone chloride derivative is dissolved in a solvent.
并且,作为用于本发明的含有氯化吖丁啶酮衍生物的溶液(A),可使用以溶剂溶解上述氯化吖丁啶酮衍生物(化合物(1a))、并调节到预定浓度后的溶液。In addition, as the solution (A) containing the chlorinated azetidinone derivative used in the present invention, the above-mentioned chlorinated azetidinone derivative (compound (1a)) dissolved in a solvent and adjusted to a predetermined concentration can be used. The solution.
含有氯化吖丁啶酮衍生物的溶液(A)是使用以溶剂溶解上述氯化吖丁啶酮衍生物(化合物(1))、并调节到预定浓度的溶液。The solution (A) containing the chlorinated azetidinone derivative is a solution in which the above-mentioned chlorinated azetidinone derivative (compound (1)) is dissolved in a solvent and adjusted to a predetermined concentration.
作为可溶解氯化吖丁啶酮衍生物的溶剂,可以举出例如甲酸甲酯、甲酸乙酯、乙酸甲酯、乙酸乙酯、乙酸丁酯、丙酸乙酯等酯类;二氯甲烷、氯仿、四氯化碳、二氯乙烷、二溴乙烷、氯苯等卤代烃;二乙醚、二丁醚、二噁烷、四氢呋喃等醚类;乙腈、丁腈等腈类;戊烷、己烷、环己烷等烃类,这些溶剂可以使用一种或两种以上(下面称为“溶剂A”)。其中优选为二噁烷。As the solvent which can dissolve the chlorinated azetidinone derivatives, for example, esters such as methyl formate, ethyl formate, methyl acetate, ethyl acetate, butyl acetate, ethyl propionate; dichloromethane, Chloroform, carbon tetrachloride, dichloroethane, dibromoethane, chlorobenzene and other halogenated hydrocarbons; diethyl ether, dibutyl ether, dioxane, tetrahydrofuran and other ethers; acetonitrile, butyronitrile and other nitriles; pentane , hexane, cyclohexane and other hydrocarbons, these solvents can use one or more than two (hereinafter referred to as "solvent A"). Among them, dioxane is preferred.
这些溶剂的含量,相对于100重量份的氯化吖丁啶酮衍生物(化合物(1))为50~500重量份,优选100~500重量份。The content of these solvents is 50 to 500 parts by weight, preferably 100 to 500 parts by weight, based on 100 parts by weight of the chlorinated azetidinone derivative (compound (1)).
可以将这样的溶解有氯化吖丁啶酮衍生物后的溶液原样使用,但由于这样的溶液粘度很高,因此优选在这样的溶液中添加可溶解氯化吖丁啶酮衍生物的醇(在下面称为“溶剂A2”)来降低粘度,以便于滴加时的操作。就可以使用的醇来说,例如可使用甲醇、乙醇、异丙醇、正丙醇等低级醇中的一种或两种以上。其中作为所用的低级醇,如果使用甲醇或乙醇在下述反应条件下进行反应时,因为能够以高收率而且高纯度地得到以上述通式(2)表示的3-氯甲基-3-头孢烯衍生物结晶,所以是特别优选的。Such a solution in which the chlorinated azetidinone derivative is dissolved can be used as it is, but since such a solution has a high viscosity, it is preferable to add an alcohol ( Hereinafter referred to as "solvent A2") to reduce the viscosity to facilitate handling during dropwise addition. Usable alcohols include, for example, one or two or more of lower alcohols such as methanol, ethanol, isopropanol, and n-propanol. Wherein as the lower alcohol used, if use methyl alcohol or ethanol to carry out the reaction under the following reaction conditions, because can obtain with the 3-chloromethyl-3-cephalosporin represented by above-mentioned general formula (2) with high yield and high purity Alkene derivatives crystallize and are therefore particularly preferred.
此时,醇(A2溶剂)的配比量,优选为相对于100重量份的氯化吖丁啶酮衍生物(化合物(1))在100~500重量份、更优选为200~300重量份的范围内。At this time, the proportioning amount of the alcohol (A2 solvent) is preferably 100 to 500 parts by weight, more preferably 200 to 300 parts by weight, relative to 100 parts by weight of the chlorinated azetidinone derivative (compound (1)). In the range.
含有这样的氯化吖丁啶酮衍生物的溶液,其氯化吖丁啶酮衍生物(化合物(1))的含量为0.05~1mol/L,优选为0.1~0.5mol/L。The solution containing such a chlorinated azetidinone derivative has a content of the chlorinated azetidinone derivative (compound (1)) of 0.05 to 1 mol/L, preferably 0.1 to 0.5 mol/L.
<含有醇盐的溶液(B)><Alkoxide-containing solution (B)>
本发明特征为:在结晶反应中使用醇盐。The present invention is characterized in that an alkoxide is used in the crystallization reaction.
可用于本发明的醇盐用通式R4-OM表示。式中的R4是碳原子数1~4的直链或支链的低级烷基,例如可以举出甲基、乙基、异丙基、正丁基等烷基。式中的M表示锂、钠、钾等碱金属。Alkoxides useful in the present invention are represented by the general formula R4 -OM. R 4 in the formula is a straight-chain or branched lower alkyl group having 1 to 4 carbon atoms, examples of which include alkyl groups such as methyl, ethyl, isopropyl, and n-butyl. M in the formula represents alkali metals such as lithium, sodium, and potassium.
作为醇盐化合物,具体地可以举出例如甲醇钠、乙醇钠、甲醇钾、乙醇钾、甲醇锂、乙醇锂、t-丁醇钾等,可以使用这些醇盐中的一种或两种以上。Specific examples of the alkoxide compound include sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, lithium methoxide, lithium ethoxide, and potassium t-butoxide, and one or more of these alkoxides can be used.
其中,作为醇盐,优选使用甲醇钠或乙醇钠。Among them, sodium methoxide or sodium ethoxide is preferably used as the alkoxide.
含有醇盐的溶液(B)是使用溶剂溶解上述醇盐并调节到预定浓度的溶液。The alkoxide-containing solution (B) is a solution in which the above-mentioned alkoxide is dissolved using a solvent and adjusted to a predetermined concentration.
作为溶解上述醇盐的溶剂(在下面称为“溶剂B1”),优选使用醇,具体可以举出甲醇、乙醇、异丙醇、正丁醇等,可以使用其中的一种或两种以上。其中优选使用甲醇或乙醇。Alcohol is preferably used as the solvent for dissolving the above-mentioned alkoxide (hereinafter referred to as "solvent B1"), specifically methanol, ethanol, isopropanol, n-butanol, etc., and one or more of them can be used. Among them, methanol or ethanol is preferably used.
<含醇溶液(C)><Alcoholic solution (C)>
含醇溶液至少要使用醇(在下面称为“溶剂C1”)的单独溶剂,或者与其它溶剂(在下面称为“溶剂C2”)的混合溶剂。作为可用的醇,可以举出甲醇、乙醇、异丙醇、正丁醇等低级醇,可以使用这些醇中的一种或两种以上。其中作为醇,优选使用甲醇或乙醇。The alcohol-containing solution uses at least a single solvent of alcohol (hereinafter referred to as "solvent C1"), or a mixed solvent with other solvents (hereinafter referred to as "solvent C2"). Usable alcohols include lower alcohols such as methanol, ethanol, isopropanol, and n-butanol, and one or two or more of these alcohols can be used. Among them, methanol or ethanol is preferably used as the alcohol.
醇可溶解以通式(1)表示的原料氯化吖丁啶酮衍生物,但为了不致溶解以通式(2)表示的反应生成物3-氯甲基-3-头孢烯衍生物,优选使用能够使反应生成物作为直接结晶回收的反应溶剂。Alcohol can dissolve the raw material chloride azetidinone derivative represented by general formula (1), but in order not to dissolve the reaction product 3-chloromethyl-3-cephem derivative represented by general formula (2), preferably A reaction solvent capable of recovering the reaction product as direct crystallization is used.
并且由于与醇(溶剂C1)混合的其它溶剂(溶剂C2)可溶解原料氯化吖丁啶酮衍生物(化合物(1)),并可溶解反应结束时成为杂质的未反应原料氯化吖丁啶酮衍生物或反应副产物等杂质,所以可由反应液中高纯度地回收以上述通式(2)表示的3-氯甲基-3-头孢烯衍生物结晶。作为这样的溶剂,可以举出例如甲酸甲酯、甲酸乙酯、乙酸甲酯、乙酸乙酯、乙酸丁酯、丙酸乙酯等酯类;二氯甲烷、氯仿、四氯化碳、二氯乙烷、二溴乙烷、氯苯等卤代烃;二乙醚、二丁醚、二噁烷、四氢呋喃等醚类;乙腈、丁腈等腈类;苯、己烷、环己烷等烃类,可以使用这些溶剂中的一种或两种以上。其中优选使用二噁烷。And because the other solvent (solvent C2) mixed with alcohol (solvent C1) can dissolve the raw material chlorinated azetidinone derivative (compound (1)), and can dissolve the unreacted raw material azetidine chloride which becomes an impurity at the end of the reaction Impurities such as pyridone derivatives and reaction by-products, so the crystals of 3-chloromethyl-3-cephem derivatives represented by the above general formula (2) can be recovered with high purity from the reaction solution. Examples of such solvents include esters such as methyl formate, ethyl formate, methyl acetate, ethyl acetate, butyl acetate, and ethyl propionate; dichloromethane, chloroform, carbon tetrachloride, dichloromethane Halogenated hydrocarbons such as ethane, dibromoethane, and chlorobenzene; ethers such as diethyl ether, dibutyl ether, dioxane, and tetrahydrofuran; nitriles such as acetonitrile and butyronitrile; hydrocarbons such as benzene, hexane, and cyclohexane , one or two or more of these solvents may be used. Among them, dioxane is preferably used.
如果醇(溶剂C1)和其它溶剂(溶剂C2),以相对于100重量份的醇(溶剂C1),其它溶剂(溶剂C2)为10~30重量份,优选10~20重量份的混合比例,在下述条件下进行反应,就能够以高收率和高纯度得到以上述通式(2)表示的3-氯甲基-3-头孢烯衍生物晶体,因此为优选,另一方面,当其它溶剂(溶剂C2)不到10重量份时,随着反应的进行,生成的3-氯甲基-3-头孢烯衍生物结晶就会在结晶时与反应副产物等杂质结成团状,从而不能以高纯度和高收率得到3-氯甲基-3-头孢烯衍生物结晶,当超过30重量份时,由于生成的3-氯甲基-3-头孢烯衍生物结晶溶解而导致收率降低,因此不予采用。If alcohol (solvent C1) and other solvents (solvent C2), with respect to the alcohol (solvent C1) of 100 weight parts, other solvents (solvent C2) are 10~30 weight parts, preferred 10~20 weight parts mixing ratio, Carrying out the reaction under the following conditions can obtain the 3-chloromethyl-3-cephem derivative crystal represented by the above general formula (2) with high yield and high purity, so it is preferred, on the other hand, when other When solvent (solvent C2) is less than 10 parts by weight, along with the progress of reaction, the crystallization of 3-chloromethyl-3-cephem derivatives that generates will agglomerate with impurities such as reaction by-products during crystallization, thereby Can not obtain 3-chloromethyl-3-cephem derivative crystals with high purity and high yield, when exceeding 30 parts by weight, because the 3-chloromethyl-3-cephem derivative crystals of generation dissolve and cause yield rate is reduced and therefore not used.
含醇溶液(C)的用量,相对于100重量份的以上述通式(1)表示的氯化吖丁啶酮衍生物,优选使用300~2000重量份,更优选500~1000重量份,当不到500重量份时,反应难以进行,同时会残留未反应的原料,而超过1000重量份时,由于要使用多于必要量的溶剂,在工业上是不利的。The amount of the alcohol-containing solution (C) is preferably 300 to 2000 parts by weight, more preferably 500 to 1000 parts by weight, relative to 100 parts by weight of the chlorinated azetidinone derivative represented by the above general formula (1), when When it is less than 500 parts by weight, the reaction is difficult to proceed and unreacted raw materials remain, and when it exceeds 1000 parts by weight, it is industrially unfavorable to use more solvent than necessary.
<反应条件><reaction conditions>
本发明的以上述通式(2)表示的3-氯甲基-3-头孢烯衍生物结晶的制造方法,其特征在于,将含有以上述通式(1)表示的氯化吖丁啶酮衍生物的溶液(A)和含有上述醇盐的溶液(B)滴加到含醇溶液(C)中,在pH为8以下的条件下进行反应。The method for producing 3-chloromethyl-3-cephem derivative crystals represented by the above general formula (2) of the present invention is characterized in that azetidinone chloride represented by the above general formula (1) is The solution (A) of the derivative and the solution (B) containing the above-mentioned alkoxide are added dropwise to the alcohol-containing solution (C), and the reaction is carried out at a pH of 8 or less.
在本发明中,在pH值8以下、优选在pH值6~8进行反应。将反应中的pH值定在此范围的理由是因为反应生成物3-氯甲基-3-头孢烯衍生物结晶对碱极不稳定,在pH值8以上时,在反应过程中就会分解,而不能以高纯度和高收率得到目的物3-氯甲基-3-头孢烯衍生物结晶,因此不予选用。In the present invention, the reaction is carried out at a pH value below 8, preferably at a pH value of 6-8. The reason why the pH value in the reaction is set in this range is because the reaction product 3-chloromethyl-3-cephem derivative crystal is extremely unstable to alkali, and when the pH value is above 8, it will decompose during the reaction process , but cannot obtain the crystallization of the target 3-chloromethyl-3-cephem derivative with high purity and high yield, so it is not selected.
由于反应进行很快,反应中pH值的测定优选为,例如由反应体系中取出反应液到石蕊试纸上,在上面滴加水来进行测定,或采取少量反应液,在添加两倍的水后,由pH计等进行测定。由于未反应醇盐表示弱碱性基团,所以反应中的pH值上升,而更加倾向于碱性。Because the reaction is carried out very quickly, the measurement of the pH value in the reaction is preferably, for example, taking out the reaction solution from the reaction system and putting it on litmus paper, and then adding water dropwise to measure it, or taking a small amount of the reaction solution, adding twice the amount of water , measured by a pH meter, etc. Since the unreacted alkoxide represents a weakly basic group, the pH in the reaction rises and tends to be more basic.
因此,在本发明中的反应,优选在上述pH值的范围内将含有氯化吖丁啶酮衍生物(化合物(1))的溶液(A)和含有醇盐的溶液(B)滴加到含醇溶液(C)中。Therefore, in the reaction in the present invention, the solution (A) containing the chlorinated azetidinone derivative (compound (1)) and the solution (B) containing the alkoxide are preferably added dropwise in the range of the above-mentioned pH value. Alcoholic solution (C).
并且,含有以上述通式(1)表示的氯化吖丁啶酮衍生物的溶液(A)和含有上述醇盐的溶液(B)的滴加量,如果以相对于含有氯化吖丁啶酮衍生物的溶液(A)中的氯化吖丁啶酮衍生物(化合物(1))的含有醇盐的溶液(B)中的醇盐的摩尔比为0.8~1.5倍mol、优选1.1~1.2倍mol的比例滴加,由于可减少未反应原料氯化吖丁啶酮衍生物(化合物(1))的残留量,就能够以高纯度和高收率得到生成的3-氯甲基-3-头孢烯衍生物结晶,所以是优选的,而在不到0.8倍mol时,未反应原料氯化吖丁啶酮衍生物(化合物(1))的残留量在必要值以上,而如果超过1.5倍mol时,反应液的pH值就会超过8而呈碱性,生成的3-氯甲基-3-头孢烯衍生物结晶会分解,因此不予选用。And, the dripping amount of the solution (A) containing the chloride azetidine derivative represented by the above-mentioned general formula (1) and the solution (B) containing the above-mentioned alkoxide, if expressed with respect to containing azetidine chloride The molar ratio of the alkoxide in the alkoxide-containing solution (B) of the chlorinated azetidinone derivative (compound (1)) in the solution (A) of the ketone derivative is 0.8 to 1.5 times mol, preferably 1.1 to The ratio of 1.2 times mol is added dropwise, because the residual amount of unreacted raw material chloride azetidinone derivative (compound (1)) can be reduced, the 3-chloromethyl- 3-cephem derivatives are crystallized, so it is preferred, and when less than 0.8 times mol, the residual amount of unreacted raw material chloride azetidinone derivatives (compound (1)) is more than the necessary value, and if it exceeds When it is 1.5 times mol, the pH value of the reaction solution will exceed 8 and be alkaline, and the generated 3-chloromethyl-3-cephem derivative crystals will decompose, so they are not selected.
另外,含有上述氯化吖丁啶酮衍生物的溶液(A)和含有上述醇盐的溶液(B)的滴加量,优选为使得它们在滴加结束时的溶液(A)~溶液(C)的全部反应溶剂中(溶剂A1+溶剂A2+溶剂B1+溶剂C1+溶剂C2)的醇含量(溶剂A2+溶剂B1+溶剂C1)为30~95重量%,优选为60~90重量%。如果滴加结束时的反应溶剂中醇含量不到30重量%时,反应原料的醇盐难以溶解在反应液中,并且会导致3-氯甲基-3-头孢烯衍生物结晶溶解而降低收率,另一方面,如果按照超过95重量%的比例进行反应,由于不能溶解生成的3-氯甲基-3-头孢烯衍生物结晶在结晶时的反应副产物等杂质,使这些杂质结成团状,所以就不能以高纯度和高收率得到3-氯甲基-3-头孢烯衍生物结晶,因此不予选用。In addition, the dropwise addition amount of the solution (A) containing the above-mentioned azetidinone derivative and the solution (B) containing the above-mentioned alkoxide is preferably such that the solution (A) to the solution (C) at the end of the dropwise addition ) in all reaction solvents (solvent A1+solvent A2+solvent B1+solvent C1+solvent C2) alcohol content (solvent A2+solvent B1+solvent C1) is 30~95% by weight, preferably 60~90% by weight. If the alcohol content in the reaction solvent at the end of the dropwise addition is less than 30% by weight, the alkoxide of the reaction raw material is difficult to dissolve in the reaction solution, and will cause the crystallization of 3-chloromethyl-3-cephem derivatives to dissolve and reduce the yield. On the other hand, if the reaction is carried out at a ratio of more than 95% by weight, impurities such as reaction by-products during crystallization of the 3-chloromethyl-3-cephem derivative crystals generated cannot be dissolved, and these impurities are formed. Agglomerates, so the 3-chloromethyl-3-cephem derivative crystals cannot be obtained with high purity and high yield, so they are not selected.
特别是在本发明中,如果对于含有氯化吖丁啶酮衍生物(化合物(1))的溶液(A),作为可溶解氯化吖丁啶酮衍生物的溶剂,使用了二噁烷(溶剂A1)与甲醇和/或乙醇(溶剂A2)的混合溶剂,作为含有醇盐的溶液(B),使用了甲醇和/或乙醇(溶剂B1),并且,作为含醇溶剂(C)使用了甲醇和/或乙醇(溶剂C1)与二噁烷(溶剂C2)的混合溶剂,在滴加结束时的反应溶剂(溶剂A1+溶剂A2+溶剂B1+溶剂C1+溶剂C2)中的甲醇和/或乙醇的含量为20~60重量%,优选为30~50重量%,就能够以高收率和高纯度得到以上述通式(2)表示的3-氯甲基-3-头孢烯衍生物结晶,因此是特别优选的。Especially in the present invention, if for the solution (A) containing the chlorinated azetidinone derivative (compound (1)), dioxane ( A mixed solvent of solvent A1) and methanol and/or ethanol (solvent A2), using methanol and/or ethanol (solvent B1) as the alkoxide-containing solution (B), and using The mixed solvent of methanol and/or ethanol (solvent C1) and dioxane (solvent C2), the content of methanol and/or ethanol in the reaction solvent (solvent A1+solvent A2+solvent B1+solvent C1+solvent C2) at the end of dropwise addition 20 to 60% by weight, preferably 30 to 50% by weight, the 3-chloromethyl-3-cephem derivative crystal represented by the above general formula (2) can be obtained with high yield and high purity. particularly preferred.
将含有上述氯化吖丁啶酮衍生物(化合物(1))的溶液(A)和含有上述醇盐的溶液(B)滴加到含醇溶液(C)中的方法,可以举出如下所述的1~2的滴加方法。The method of adding dropwise the solution (A) containing the above-mentioned azetidinone derivative (compound (1)) and the solution (B) containing the above-mentioned alkoxide to the alcohol-containing solution (C) includes the following: The dripping method of 1-2 mentioned above.
1.配制含有以上述通式(1)表示的氯化吖丁啶酮衍生物的溶液(溶液A)和含有上述醇盐的溶液(B),在滴加含有上述醇盐的溶液(B)之前,滴加含有上述氯化吖丁啶酮衍生物的溶液(A),将溶液(A)和(B)连续地或断续地滴加到含醇溶液(C)中,使反应体系的pH值处于上述范围内的方法(下文称为“滴加方法1”。)。1. preparation contains the solution (solution A) of the chlorinated azetidinone derivative represented by above-mentioned general formula (1) and the solution (B) containing above-mentioned alkoxide, in dropwise adding the solution (B) containing above-mentioned alkoxide Before, the solution (A) containing the above-mentioned azetidinone chloride derivatives was added dropwise, and the solutions (A) and (B) were continuously or intermittently added dropwise to the alcohol-containing solution (C), so that the reaction system A method in which the pH is within the above range (hereinafter referred to as "dropping method 1.").
2.配制含有以上述通式(1)表示的氯化吖丁啶酮衍生物的溶液(A),首先使氯化吖丁啶酮衍生物的反应当量为5~30mol%、优选为10~20mol%地将上述溶液(A)滴加到含醇溶液(C)中,然后将其余部分的含有以上述通式(1)表示的氯化吖丁啶酮衍生物的溶液(A)与含有醇盐的溶液(B),同时滴加到含醇溶液(C)中,使反应体系的pH值处于上述范围内的方法(下文称为“滴加方法2”。)。2. preparation contains the solution (A) of the chlorinated azetidinone derivative represented by the above-mentioned general formula (1), at first making the reaction equivalent of the chlorinated azetidinone derivative be 5~30mol%, preferably 10~ 20mol% of the above-mentioned solution (A) is added dropwise in the alcohol-containing solution (C), and then the rest of the solution (A) containing the azetidinone chloride derivative represented by the above general formula (1) is mixed with the solution (A) containing The solution (B) of alkoxide is added dropwise in the alcohol-containing solution (C) at the same time, so that the pH value of the reaction system is in the method of the above-mentioned range (hereinafter referred to as "dropping method 2".).
上述滴加方法1是适当地调节含有氯化吖丁啶酮衍生物的溶液(A)和含有醇盐的溶液(B)的滴加顺序,使反应体系内的pH值总是处于上述范围内的将含有上述氯化吖丁啶酮衍生物的溶液(A)和含有醇盐的溶液(B)滴加到含醇溶液(C)中的方法。而滴加方法2,是在含醇溶液(C)中预先滴加预定量的含有氯化吖丁啶酮衍生物的溶液(A),使反应体系处于酸性范围内(例如pH值为4),此时将其余的含有氯化吖丁啶酮衍生物的溶液(A)和含有醇盐的溶液(B)几乎同时地连续地滴加到含醇溶液(C)中,使反应体系内的pH值总是处于上述范围内的滴加方法。The above-mentioned dropping method 1 is to properly adjust the dropping order of the solution (A) containing the chlorinated azetidinone derivative and the solution (B) containing the alkoxide, so that the pH value in the reaction system is always within the above-mentioned range A method in which the solution (A) containing the above-mentioned azetidinone chloride derivative and the solution (B) containing the alkoxide are added dropwise to the alcohol-containing solution (C). And dropwise method 2 is to add predetermined amount of solution (A) containing azetidinone derivatives dropwise in advance in the alcoholic solution (C), so that the reaction system is in the acidic range (for example, the pH value is 4) , at this time, the rest of the solution (A) containing the chlorinated azetidinone derivative and the solution (B) containing the alkoxide are continuously added dropwise to the alcohol-containing solution (C) almost simultaneously, so that the reaction system A dropwise addition method in which the pH is always within the above range.
另外,在本发明的3-氯甲基-3-头孢烯衍生物结晶的制造方法中,也可以在配制含醇溶液(C)时,先将含量为5~30mol%,优选10~30mol%的上述氯化吖丁啶酮衍生物加入到含醇溶液(C)中,然后按照与滴加方法2相同的操作,再同时在含醇溶液(C)中滴加含有反应所需量的氯化吖丁啶酮衍生物的溶液和含有醇盐的溶液,使反应体系中的pH值总是保持在上述范围内。In addition, in the method for producing 3-chloromethyl-3-cephem derivative crystals of the present invention, when preparing the alcohol-containing solution (C), the content is 5-30 mol%, preferably 10-30 mol%. The above-mentioned chlorinated azetidinone derivatives are added to the alcoholic solution (C), and then according to the same operation as the dropwise addition method 2, then in the alcoholic solution (C), dropwise add chlorine containing the required amount of reaction. The solution of the azetidinone derivative and the solution containing the alkoxide keep the pH value in the reaction system always within the above-mentioned range.
在本发明的反应中,反应生成物3-氯甲基-3-头孢烯衍生物结晶对碱极不稳定,当pH值在8以上时,在反应中会分解,如果从一开始就将含有氯化吖丁啶酮衍生物的溶液(A)和含有醇盐的溶液(B)同时滴加到含醇溶液(C)中,由于会向碱性一方移动,所以如上述滴加方法1、2所示,优选为先连续不断地加入氯化吖丁啶酮衍生物(化合物(1)),并使反应进行时pH值不超过呈碱性的8。另外,含有氯化吖丁啶酮衍生物的溶液(A)pH值大约是4,通过添加含有醇盐的溶液(B)使反应体系的pH值上升。In the reaction of the present invention, the reaction product 3-chloromethyl-3-cephem derivative crystal is extremely unstable to alkali, and when the pH value is above 8, it will decompose in the reaction, if it will contain The solution (A) of chlorinated azetidinone derivatives and the solution (B) containing alkoxide are added dropwise in the alcohol-containing solution (C) at the same time, because they will move to the alkaline side, so as the above-mentioned drop method 1, As shown in 2, it is preferable to add the azetidinone chloride derivative (compound (1)) continuously first, and make the pH value not exceed 8 which is basic when the reaction is carried out. In addition, the pH value of the solution (A) containing the chloride azetidinone derivative is about 4, and the pH value of the reaction system is raised by adding the solution (B) containing the alkoxide.
在本发明中,在上述滴加方法1、2中,从容易控制pH值这一点上看,滴加方法2在工业上特别有利。In the present invention, among the above-mentioned dropping methods 1 and 2, the dropping method 2 is particularly industrially advantageous in terms of easy pH control.
并且,在本发明中,当将含有原料氯化吖丁啶酮衍生物的溶液(A)全部加入含醇溶液(C)以后,滴加含有醇盐的溶液(B)在pH为8以下进行反应时,随着反应进行,生成的反应生成物3-氯甲基-3-头孢烯衍生物结晶中有可能含有杂质,从而造成品质降低,但由于能够不间断地得到结晶,尽管增加了后面精制工序的负担,但反应能以简单的操作进行。And, in the present invention, after all the solution (A) containing the raw material chlorinated azetidinone derivatives is added to the alcohol-containing solution (C), the dropwise addition of the solution (B) containing alkoxide is carried out at a pH of 8 or less. During the reaction, as the reaction proceeds, the resulting reaction product 3-chloromethyl-3-cephem derivative crystals may contain impurities, thereby causing a reduction in quality, but since the crystallization can be obtained without interruption, although the subsequent The burden of the purification process, but the reaction can be carried out with simple operation.
在本发明中,可以将由得到原料氯化吖丁啶酮衍生物之前的工序中的吖丁啶酮衍生物的氯化反应得到的氯化吖丁啶酮衍生物的溶液用作含有氯化吖丁啶酮的原料溶液(A)。此溶液可举出,例如用特公平5-9425中所述的方法,由吖丁啶酮衍生物的氯化反应制造的吖丁啶酮衍生物的溶液。如果使用这样的溶液,可以从前一道制造工序的原料吖丁啶酮衍生物开始,通过连续的工序得到本发明的目的物3-氯甲基-3-头孢烯衍生物结晶。In the present invention, the solution of the chlorinated azetidinone derivative obtained by the chlorination reaction of the azetidinone derivative in the process before obtaining the raw material chlorinated azetidinone derivative can be used as a Raw material solution (A) of butyridinone. Examples of such solutions include solutions of azetidinone derivatives produced by chlorination of azetidinone derivatives by the method described in JP-A-5-9425. If such a solution is used, crystals of the 3-chloromethyl-3-cephem derivative which is the object of the present invention can be obtained through continuous steps starting from the azetidinone derivative which is the raw material in the previous manufacturing step.
在本发明的制造方法中,含有原料氯化吖丁啶酮衍生物的溶液(A),优选使用氯化吖丁啶酮衍生物溶解于二噁烷中的二噁烷溶液,由于二噁烷溶液中的二噁烷熔点是11℃,当在例如10℃以下的反应温度下进行反应的情况下,有可能造成溶液粘度上升,甚至凝固,为了防止此现象,可以通过添加能够溶解氯化吖丁啶酮衍生物的甲醇或乙醇等醇进行稀释,降低溶液的粘度,使得滴加易于进行。In the production method of the present invention, the solution (A) containing the raw material chlorinated azetidinone derivative is preferably a dioxane solution in which the chlorinated azetidinone derivative is dissolved in dioxane, because dioxane The melting point of dioxane in the solution is 11°C. For example, when the reaction is carried out at a reaction temperature below 10°C, the viscosity of the solution may increase or even solidify. Alcohols such as methanol or ethanol dilute the butidinone derivatives to reduce the viscosity of the solution, making the dropwise addition easy.
并且,在本发明的制造方法中,优选通过含有用作反应溶剂的二噁烷的反应体系进行反应,如果二噁烷的含量少,由于随着反应进行,生成的反应生成物3-氯甲基-3-头孢烯衍生物结晶与结晶时的反应副产物等杂质会结合成团状物,所以,反应体系中二噁烷的含量,相对于氯化吖丁啶酮衍生物来说,维持在10~30重量份的范围是优选的。In addition, in the production method of the present invention, it is preferable to carry out the reaction through a reaction system containing dioxane used as a reaction solvent. If the content of dioxane is small, the resulting reaction product 3-chloromethane Impurities such as crystallization of base-3-cephem derivatives and reaction by-products during crystallization will combine into agglomerates, so the content of dioxane in the reaction system maintains The range of 10 to 30 parts by weight is preferable.
并且,由于在本发明的制造方法中,反应在反应溶剂中进行,在反应中也不会生成水,是在无水状态下进行反应,所以就具有:没有因醇盐溶于水而产生碱的作用,易于防止由碱造成的3-氯甲基-3-头孢烯衍生物结晶的分解的优点。And, because in the manufacture method of the present invention, reaction is carried out in reaction solvent, also can not generate water in reaction, is to react under anhydrous state, so just have: do not produce alkali because alkoxide is dissolved in water The role of easy to prevent the decomposition of 3-chloromethyl-3-cephem derivative crystals caused by alkali.
在本发明的制造方法之所以为优选,是因为上述反应是在5℃以下的反应温度下进行,这就抑制了副产物的形成,从而能够以高收率得到作为目的物的以上述通式(2)表示的3-氯甲基-3-头孢烯衍生物结晶。另一方面,由于在低于-20℃的情况下原料、杂质会析出,所以在-20~5℃、优选在-10~5℃下进行反应。The reason why the production method of the present invention is preferred is because the above-mentioned reaction is carried out at a reaction temperature below 5° C., which suppresses the formation of by-products, so that the target product of the above-mentioned general formula can be obtained in high yield. Crystals of the 3-chloromethyl-3-cephem derivative represented by (2). On the other hand, since raw materials and impurities are precipitated at lower than -20°C, the reaction is carried out at -20 to 5°C, preferably at -10 to 5°C.
这样,通过作为目的物的以上述通式(2)表示的3-氯甲基-3-头孢烯衍生物的结晶反应,通过反应液变白、混浊而可随时判断结晶析出,反应结束后,经中和、过滤、干燥而得到结晶。如有必要也可以通过洗净、重结晶进行精制。In this way, by the crystallization reaction of the 3-chloromethyl-3-cephem derivative represented by the above-mentioned general formula (2) as the object, the crystallization can be judged at any time by the reaction solution becoming white and turbid, and after the reaction is finished, After neutralization, filtration and drying, crystallization was obtained. If necessary, it can also be refined by washing and recrystallization.
作为可用于洗净和重结晶的溶剂,可以适当地选择例如甲醇、乙醇、异丙醇、正丁醇等醇;乙腈、丁腈等腈类;丙酮、甲乙酮等酮类;二甲基甲酰胺、二乙基甲酰胺等酰胺类等当中的一种或两种以上。As solvents that can be used for washing and recrystallization, for example, alcohols such as methanol, ethanol, isopropanol, and n-butanol; nitriles such as acetonitrile and butyronitrile; ketones such as acetone and methyl ethyl ketone; dimethylformamide , diethylformamide and other amides, or one or more of them.
并且,按照本发明的以上述通式(2)表示的3-氯甲基-3-头孢烯衍生物结晶的制造方法,由例如氯化吖丁啶酮衍生物(化合物(1a))和醇盐(化合物(7))按照如下的反应式(5)进行反应,And, according to the production method of the 3-chloromethyl-3-cephem derivative crystal represented by the above-mentioned general formula (2) of the present invention, for example, azetidinone chloride derivative (compound (1a)) and alcohol Salt (compound (7)) reacts according to following reaction formula (5),
反应式(5)Reaction formula (5)
(式中,R1表示取代或未取代的芳香族烃基,R4表示有机基团,M表示碱金属)。(wherein, R 1 represents a substituted or unsubstituted aromatic hydrocarbon group, R 4 represents an organic group, and M represents an alkali metal).
在生成作为目的物的3-氯甲基-3-头孢烯衍生物结晶(化合物(2a))的同时,还有磺酸金属盐(化合物(8))副产物生成。例如,回收3-氯甲基-3-头孢烯衍生物结晶,由回收后的母液使磺酸金属盐结晶析出(化合物(8)),然后使该析出的磺酸金属盐在溶剂中与溴反应,得到磺酰溴,可以作为例如上述反应式(3)的噻唑啉吖丁啶酮衍生物(化合物(4))的制造原料重新利用。Simultaneously with formation of the target 3-chloromethyl-3-cephem derivative crystal (compound (2a)), a sulfonic acid metal salt (compound (8)) was produced as a by-product. For example, reclaim 3-chloromethyl-3-cephem derivative crystallization, make sulfonic acid metal salt crystallization (compound (8)) by the mother liquor after recovery, then make the sulfonic acid metal salt of this precipitation in solvent and bromine The reaction yields sulfonyl bromide, which can be reused as a raw material for the production of, for example, the thiazolinazetidinone derivative (compound (4)) of the above reaction formula (3).
用本发明的制造方法得到的由上述通式(2)表示的3-氯甲基-3-头孢烯衍生物结晶,在温和的条件下具有优异的长期稳定性,例如,The 3-chloromethyl-3-cephem derivative crystals represented by the above general formula (2) obtained by the production method of the present invention have excellent long-term stability under mild conditions, for example,
按照如下反应式(6),According to the following reaction formula (6),
反应式(6)Reaction formula (6)
就能够衍生为可用作各种头孢菌素系抗生素的7-氨基-3-氯甲基-3-头孢烯衍生物(化合物(9))。It can be derivatized into 7-amino-3-chloromethyl-3-cephem derivatives (compound (9)) which can be used as various cephalosporin antibiotics.
实施例Example
下面根据实施例详细地说明本发明,但本发明并非仅限于此。The present invention will be described in detail below based on examples, but the present invention is not limited thereto.
实施例1Example 1
将68.6g(0.052mol)含有47.7重量%的以下述化合物(10)68.6g (0.052mol) containing 47.7% by weight of the following compound (10)
表示的氯化吖丁啶酮衍生物(化合物(10))的二噁烷溶液加入用氮气置换的滴液漏斗中,添加50g无水甲醇(关东化学试药)稀释作为A液。A dioxane solution of the indicated azetidinone chloride derivative (compound (10)) was placed in a dropping funnel purged with nitrogen, and diluted with 50 g of anhydrous methanol (Kanto Chemical Co., Ltd.) to obtain liquid A.
将13.5g(0.060mol)含有24重量%甲醇钠的甲醇溶液(试剂1级)用67.2g无水甲醇稀释,配制成含有4重量%甲醇钠的甲醇溶液,作为B液。Dilute 13.5 g (0.060 mol) of a methanol solution containing 24 wt % sodium methoxide (reagent grade 1) with 67.2 g of anhydrous methanol to prepare a methanol solution containing 4 wt % sodium methoxide as liquid B.
在反应用烧瓶中,加入13g二噁烷,加入160mL无水乙醇,冷却到-2~2℃。在加入有冷却的反应溶剂的四口烧瓶中,将上述A液总量的1/8(pH值为4)加入到上述配制好的反应溶剂中。In the reaction flask, add 13g of dioxane, add 160mL of absolute ethanol, and cool to -2~2°C. In the four-neck flask filled with the cooled reaction solvent, add 1/8 of the total amount of the above liquid A (pH value is 4) into the above prepared reaction solvent.
然后,一边将反应体系的温度维持在-2~2℃之间,一边同时滴加上述A液和B液。当滴加了大约1/8的B液后,反应液开始出现白色混浊,成为含有白色结晶的浆液。然后一边将反应体系的温度维持在-2~2℃之间,一边同时滴加上述A液和B液,大约经4小时滴加完毕(pH值为7~8)。滴加结束以后,再在0℃下搅拌0.25小时进行反应。Then, while maintaining the temperature of the reaction system between -2°C and 2°C, the above liquid A and liquid B were simultaneously added dropwise. After about 1/8 of liquid B was added dropwise, the reaction liquid began to appear white turbid and became a slurry containing white crystals. Then, while maintaining the temperature of the reaction system between -2 and 2°C, the above liquid A and liquid B were added dropwise at the same time, and the dropwise addition was completed in about 4 hours (pH value was 7 to 8). After completion of the dropwise addition, the mixture was further stirred at 0° C. for 0.25 hours to perform a reaction.
反应结束以后,在反应结束后的反应液中添加0.48g醋酸进行中和。中和后的反应体系pH值为4~5。在中和处理后,再就这样地在-2~2℃下搅拌0.5小时进行熟化。After the reaction was completed, 0.48 g of acetic acid was added to the reaction solution after the reaction for neutralization. The pH value of the neutralized reaction system is 4-5. After the neutralization treatment, the mixture was further aged with stirring at -2 to 2°C for 0.5 hours.
然后,在熟化结束以后,用3G玻璃过滤器过滤,以18g用冰冷却的甲醇淋洗得到的滤饼,再用36g含水30%的甲醇溶液进行第二次淋洗,以18g用冰冷却的甲醇进行第三次淋洗。Then, after the aging is finished, filter with a 3G glass filter, rinse the obtained filter cake with 18g of ice-cooled methanol, then use 36g of 30% methanol solution containing water for the second rinse, and rinse with 18g of ice-cooled methanol. Methanol for the third rinse.
将经过洗涤处理的滤饼放入干燥器中,在室温下放置一夜,用真空泵干燥,得到22.9g的3-氯甲基-3-头孢烯衍生物结晶(通式(2a))(纯度94.1%,收率85.1%)。Put the washed filter cake into a desiccator, place it overnight at room temperature, and dry it with a vacuum pump to obtain 22.9 g of 3-chloromethyl-3-cephem derivative crystals (general formula (2a)) (purity 94.1 %, yield 85.1%).
(鉴别数据)(authentication data)
1H-NMR(δ,CDCl3) 1 H-NMR (δ, CDCl 3 )
3.41(1H,d,j=18.5),3.59(1H,d,j=18.5),4.92(1H,d,j=4.9),5.82(1H,d,d,j=4.9,9.3),6.12(1H,d,j=9.3),3.58(1H,d,j=16.1),3.67(1H,d,j=16.1),7.40~7.28(5H,m),4.39(1H,d,j=11.9),4.50(1H,d,j=11.9),5.20(2H,s),7.32(2H,d,j=8.6),6.88(2H,d,j=8.6),3.80(3H,s)3.41 (1H, d, j = 18.5), 3.59 (1H, d, j = 18.5), 4.92 (1H, d, j = 4.9), 5.82 (1H, d, d, j = 4.9, 9.3), 6.12 ( 1H, d, j = 9.3), 3.58 (1H, d, j = 16.1), 3.67 (1H, d, j = 16.1), 7.40 ~ 7.28 (5H, m), 4.39 (1H, d, j = 11.9) , 4.50 (1H, d, j = 11.9), 5.20 (2H, s), 7.32 (2H, d, j = 8.6), 6.88 (2H, d, j = 8.6), 3.80 (3H, s)
FT-IR(cm-1,KBr)FT-IR (cm -1 , KBr)
3499cm-1、3271cm-1、1778cm-1、1703cm-1、1645cm-1、1251cm-1 3499cm -1 , 3271cm -1 , 1778cm -1 , 1703cm -1 , 1645cm -1 , 1251cm -1
FAB-MSFAB-MS
M+1:487m/zM+1: 487m/z
再使用理学株式会社制造的X射线衍射装置RINT2400,利用通过单色滤光器的λ=1.5418的铜射线,对由实施例1得到的3-氯甲基-3-头孢烯衍生物结晶进行X射线衍射分析。其X射线衍射图样如表1所示。Then, using the X-ray diffraction apparatus RINT2400 manufactured by Rigaku Co., Ltd., the crystallization of the 3-chloromethyl-3-cephem derivative obtained in Example 1 was carried out using a copper ray of λ=1.5418 Å passing through a monochromatic filter. X-ray diffraction analysis. Its X-ray diffraction pattern is shown in Table 1.
表1
(注)表1中的d是晶格面间距;I/I0是相对于d=4.17衍射峰的相对强度(Note) d in Table 1 is the spacing between lattice planes; I/I 0 is the relative intensity of the diffraction peak relative to d=4.17
实施例2Example 2
将68.6g(0.052mol)含有47.7重量%的氯化吖丁啶酮衍生物(化合物(10))的二噁烷溶液加入到用氮气置换的滴液漏斗中,加入50g无水甲醇(关东化学试药)进行稀释作为A液。68.6 g (0.052 mol) of a dioxane solution containing 47.7% by weight of azetidinone derivatives (compound (10)) was added to a dropping funnel replaced with nitrogen, and 50 g of anhydrous methanol (Kanto Chemical Co., Ltd. Reagent) was diluted as solution A.
用103g甲醇溶解4.46g(0.063mol)乙醇钠,配制成含有4重量%乙醇钠的甲醇溶液,作为B液。4.46 g (0.063 mol) of sodium ethoxide was dissolved in 103 g of methanol to prepare a methanol solution containing 4% by weight of sodium ethoxide as liquid B.
在反应用烧瓶中加入13g二噁烷,加入160mL无水乙醇,冷却到-2~2℃。在加入了冷却的反应溶剂的四口烧瓶中,将上述A液总量的1/8加入到上述配制好的反应溶剂中(pH值为4)。Add 13 g of dioxane to the reaction flask, add 160 mL of absolute ethanol, and cool to -2 to 2°C. In the four-neck flask added with the cooled reaction solvent, add 1/8 of the total amount of the above liquid A into the above prepared reaction solvent (pH value is 4).
然后,一边将反应体系的温度维持在-2~2℃之间,一边同时滴加上述的A液和B液。当B液滴加了大约1/5后,反应液开始出现白色混浊,成为含有白色结晶的浆液。然后一边将反应体系的温度维持在-2~2℃之间,一边同时滴加上述A液和B液,大约经4小时滴加完毕(pH值为7~8)。滴加结束以后,再在0℃下搅拌0.25小时进行反应。Then, while maintaining the temperature of the reaction system between -2°C and 2°C, the above-mentioned liquid A and liquid B were added dropwise at the same time. When about 1/5 of the liquid B was added dropwise, the reaction liquid began to appear white turbid, and became a slurry containing white crystals. Then, while maintaining the temperature of the reaction system between -2 and 2°C, the above liquid A and liquid B were added dropwise at the same time, and the dropwise addition was completed in about 4 hours (pH value was 7 to 8). After completion of the dropwise addition, the mixture was further stirred at 0° C. for 0.25 hours to perform a reaction.
反应结束以后,在反应结束后的反应液中添加0.44g醋酸进行中和。另外,中和后反应体系的pH值为4~5。在中和处理后,再照原样在-2~2℃下搅拌0.5小时进行熟化。After the reaction was completed, 0.44 g of acetic acid was added to the reaction solution after the reaction for neutralization. In addition, the pH value of the reaction system after neutralization is 4-5. After the neutralization treatment, it was aged at -2 to 2° C. for 0.5 hour with stirring.
然后,在熟化结束以后,用3G玻璃过滤器过滤,以18g用冰冷却的甲醇淋洗得到的滤饼,再用36g含水30%的甲醇溶液进行第二次淋洗,以18g用冰冷却的甲醇进行第三次淋洗。Then, after the aging is finished, filter with a 3G glass filter, rinse the obtained filter cake with 18g of ice-cooled methanol, then use 36g of 30% methanol solution containing water for the second rinse, and rinse with 18g of ice-cooled methanol. Methanol for the third rinse.
将经过洗涤处理的滤饼放入干燥器中,在室温下放置一夜,用真空泵干燥,得到21.8g的3-氯甲基-3-头孢烯衍生物结晶(通式(2a))(纯度94.3%,收率81.2%)。Put the washed filter cake into a desiccator, place it overnight at room temperature, and dry it with a vacuum pump to obtain 21.8 g of 3-chloromethyl-3-cephem derivative crystals (general formula (2a)) (purity 94.3 %, yield 81.2%).
(鉴别数据)(authentication data)
1H-NMR(δ,CDCl3) 1 H-NMR (δ, CDCl 3 )
3.41(1H,d,j=18.5),3.59(1H,d,j=18.5),4.92(1H,d,j=4.9),5.82(1H,d,d,j=4.9,9.3),6.12(1H,d,j=9.3),3.58(1H,d,j=16.1),3.67(1H,d,j=16.1),7.40~7.28(5H,m),4.39(1H,d,j=11.9),4.50(1H,d,j=11.9),5.20(2H,s),7.32(2H,d,j=8.6),6.88(2H,d,j=8.6),3.80(3H,s)3.41 (1H, d, j = 18.5), 3.59 (1H, d, j = 18.5), 4.92 (1H, d, j = 4.9), 5.82 (1H, d, d, j = 4.9, 9.3), 6.12 ( 1H, d, j = 9.3), 3.58 (1H, d, j = 16.1), 3.67 (1H, d, j = 16.1), 7.40 ~ 7.28 (5H, m), 4.39 (1H, d, j = 11.9) , 4.50 (1H, d, j = 11.9), 5.20 (2H, s), 7.32 (2H, d, j = 8.6), 6.88 (2H, d, j = 8.6), 3.80 (3H, s)
FT-IR(cm-1,KBr)FT-IR (cm -1 , KBr)
3449cm-1、3271cm-1、1778cm-1、1251cm-1 3449cm -1 , 3271cm -1 , 1778cm -1 , 1251cm -1
FAB-MSFAB-MS
M+1:487m/zM+1: 487m/z
然后,按与实施例1同样的方法对由实施例2得到的3-氯甲基-3-头孢烯衍生物结晶进行X射线衍射分析,显示出与实施例1同样的X射线衍射图样。Then, X-ray diffraction analysis was performed on the 3-chloromethyl-3-cephem derivative crystal obtained in Example 2 in the same manner as in Example 1, and the same X-ray diffraction pattern as in Example 1 was shown.
实施例3Example 3
将69.75g(0.052mol)含有46.9重量%的氯化吖丁啶酮衍生物(化合物(10))的二噁烷溶液加入到用氮气置换的滴液漏斗中,加入50g无水甲醇(关东化学试药)进行稀释作为A液。69.75 g (0.052 mol) of a dioxane solution containing 46.9% by weight of azetidinone derivatives (compound (10)) was added to a dropping funnel replaced with nitrogen, and 50 g of anhydrous methanol (Kanto Chemical Co., Ltd. Reagent) was diluted as solution A.
用103g无水乙醇溶解4.46g(0.063mol)乙醇钠,配制成含有4重量%乙醇钠的乙醇溶液,作为B液。4.46 g (0.063 mol) of sodium ethoxide was dissolved in 103 g of absolute ethanol to prepare an ethanol solution containing 4% by weight of sodium ethoxide as liquid B.
在反应烧瓶中加入13g二噁烷,加入160mL无水乙醇,冷却到-2~2℃。在加入了冷却的反应用溶剂的四口烧瓶中,将上述A液总量的1/8加入到上述配制好的反应溶剂中(pH值4)。Add 13g of dioxane to the reaction flask, add 160mL of absolute ethanol, and cool to -2~2°C. In the four-neck flask added with the cooled reaction solvent, add 1/8 of the total amount of the above liquid A into the above prepared reaction solvent (pH value 4).
然后,一边将反应体系的温度维持在-2~2℃之间,一边同时滴加上述的A液和B液。当B液滴加了大约1/4后,反应液开始出现白色混浊,成为含有白色结晶的浆液。然后一边将反应体系的温度维持在-2~2℃之间,一边同时滴加上述A液和B液,大约4小时滴加完毕(pH值为7~8)。滴加结束以后,再在0℃下搅拌0.25小时进行反应。Then, while maintaining the temperature of the reaction system between -2°C and 2°C, the above-mentioned liquid A and liquid B were added dropwise at the same time. When about 1/4 of the liquid B was added dropwise, the reaction liquid began to appear white turbid, and became a slurry containing white crystals. Then, while maintaining the temperature of the reaction system at -2-2°C, the above liquid A and liquid B were added dropwise at the same time, and the dropwise addition was completed in about 4 hours (pH value was 7-8). After completion of the dropwise addition, the mixture was further stirred at 0° C. for 0.25 hours to perform a reaction.
反应结束以后,在反应结束后的反应液中添加0.43g醋酸进行中和。中和后反应体系的pH值为4~5。在中和处理后,再就这样地在-2~2℃下搅拌0.5小时进行熟化。After the reaction was completed, 0.43 g of acetic acid was added to the reaction solution after the reaction for neutralization. The pH value of the reaction system after neutralization is 4-5. After the neutralization treatment, the mixture was further aged with stirring at -2 to 2°C for 0.5 hours.
然后,在熟化结束以后,用3G玻璃过滤器过滤,以18g用冰冷却的甲醇淋洗得到的滤饼,再用36g含水30%的甲醇溶液进行第二次淋洗,以18g用冰冷却的甲醇进行第三次淋洗。Then, after the aging is finished, filter with a 3G glass filter, rinse the obtained filter cake with 18g of ice-cooled methanol, then use 36g of 30% methanol solution containing water for the second rinse, and rinse with 18g of ice-cooled methanol. Methanol for the third rinse.
将经过洗涤处理的滤饼放入干燥器中,在室温下放置一夜,用真空泵干燥,得到23.28g的3-氯甲基-3-头孢烯衍生物结晶(通式(2a))(纯度91.6%,收率84.2%)。Put the washed filter cake into a desiccator, place it overnight at room temperature, and dry it with a vacuum pump to obtain 23.28 g of 3-chloromethyl-3-cephem derivative crystals (general formula (2a)) (purity 91.6 %, yield 84.2%).
(鉴别数据)(authentication data)
1H-NMR(δ,CDCl3) 1 H-NMR (δ, CDCl 3 )
3.41(1H,d,j=18.5),3.59(1H,d,j=18.5),4.92(1H,d,j=4.9),5.82(1H,d,d,j=4.9,9.3),6.12(1H,d,j=9.3),3.58(1H,d,j=16.1),3.67(1H,d,j=16.1),7.40~7.28(5H,m),4.39(1H,d,j=11.9),4.50(1H,d,j=11.9),5.20(2H,s),7.32(2H,d,j=8.6),6.88(2H,d,j=8.6),3.80(3H,s)3.41 (1H, d, j = 18.5), 3.59 (1H, d, j = 18.5), 4.92 (1H, d, j = 4.9), 5.82 (1H, d, d, j = 4.9, 9.3), 6.12 ( 1H, d, j = 9.3), 3.58 (1H, d, j = 16.1), 3.67 (1H, d, j = 16.1), 7.40 ~ 7.28 (5H, m), 4.39 (1H, d, j = 11.9) , 4.50 (1H, d, j = 11.9), 5.20 (2H, s), 7.32 (2H, d, j = 8.6), 6.88 (2H, d, j = 8.6), 3.80 (3H, s)
FT-IR(cm-1,KBr)FT-IR (cm -1 , KBr)
3449cm-1、3271cm-1、1778cm-1、1251cm-1 3449cm -1 , 3271cm -1 , 1778cm -1 , 1251cm -1
FAB-MSFAB-MS
M+1:487m/zM+1: 487m/z
而且,按照与实施例1相同的方法对由实施例3得到的3-氯甲基-3-头孢烯衍生物结晶进行X射线衍射分析,显示出与实施例1同样的X射线衍射图样。Furthermore, X-ray diffraction analysis was performed on the 3-chloromethyl-3-cephem derivative crystal obtained in Example 3 in the same manner as in Example 1, and the same X-ray diffraction pattern as in Example 1 was shown.
实施例4Example 4
将64.55g(0.052mol)含有50.6重量%的氯化吖丁啶酮衍生物(化合物(10))的二噁烷溶液加入到用氮气置换的滴液漏斗中,加入50g无水甲醇(关东化学试药)进行稀释作为A液。64.55 g (0.052 mol) of a dioxane solution containing 50.6% by weight of azetidinone derivatives (compound (10)) was added to a dropping funnel replaced with nitrogen, and 50 g of anhydrous methanol (Kanto Chemical Co., Ltd. Reagent) was diluted as solution A.
用67.2g无水甲醇稀释13.5g含有24重量%甲醇钠的甲醇溶液(试剂一级),配制成含有4重量%甲醇钠(0.060mol)的甲醇溶液,作为B液。Dilute 13.5 g of a methanol solution containing 24% by weight of sodium methoxide (reagent grade 1) with 67.2 g of anhydrous methanol to prepare a methanol solution containing 4% by weight of sodium methoxide (0.060 mol) as liquid B.
在反应烧瓶中加入13g二噁烷,加入160mL无水乙醇,冷却到-2~2℃。在加入了冷却的反应用溶剂的四口烧瓶中,将上述A液总量的1/8加入到上述配制好的反应溶剂中(pH值4)。Add 13g of dioxane to the reaction flask, add 160mL of absolute ethanol, and cool to -2~2°C. In the four-neck flask added with the cooled reaction solvent, add 1/8 of the total amount of the above liquid A into the above prepared reaction solvent (pH value 4).
然后,一边将反应体系的温度维持在-2~2℃之间,一边同时滴加上述的A液和B液。当B液滴加了大约1/4后,反应液开始出现白色混浊,成为含有白色结晶的浆液。然后一边将反应体系的温度维持在-2~2℃之间,一边同时滴加上述A液和B液,大约经2小时滴加完毕(pH值为7~8)。滴加结束以后,再在0℃下搅拌0.25小时进行反应。Then, while maintaining the temperature of the reaction system between -2°C and 2°C, the above-mentioned liquid A and liquid B were added dropwise at the same time. When about 1/4 of the liquid B was added dropwise, the reaction liquid began to appear white turbid, and became a slurry containing white crystals. Then, while maintaining the temperature of the reaction system between -2 and 2°C, the above-mentioned liquid A and liquid B were added dropwise at the same time, and the dropwise addition was completed in about 2 hours (pH value was 7-8). After completion of the dropwise addition, the mixture was further stirred at 0° C. for 0.25 hours to perform a reaction.
反应结束以后,在反应结束后的反应液中添加0.48g醋酸进行中和。另外,中和后反应体系的pH值为4~5。在中和处理后,再就这样地在-2~2℃下搅拌0.5小时进行熟化。After the reaction was completed, 0.48 g of acetic acid was added to the reaction solution after the reaction for neutralization. In addition, the pH value of the reaction system after neutralization is 4-5. After the neutralization treatment, the mixture was further aged with stirring at -2 to 2°C for 0.5 hours.
然后,在熟化结束以后,用3G玻璃过滤器过滤,以18g用冰冷却的甲醇淋洗得到的滤饼,再用36g含水30%的甲醇溶液进行第二次淋洗,以18g用冰冷却的甲醇进行第三次淋洗。Then, after the aging is finished, filter with a 3G glass filter, rinse the obtained filter cake with 18g of ice-cooled methanol, then use 36g of 30% methanol solution containing water for the second rinse, and rinse with 18g of ice-cooled methanol. Methanol for the third rinse.
将经过洗涤处理的滤饼放入干燥器中,在室温下放置一夜,用真空泵干燥,得到22.58g的3-氯甲基-3-头孢烯衍生物结晶(通式(2a))(纯度94.4%,收率84.2%)。The washed filter cake is put into a desiccator, placed overnight at room temperature, and dried with a vacuum pump to obtain 22.58 g of 3-chloromethyl-3-cephem derivative crystals (general formula (2a)) (purity 94.4 %, yield 84.2%).
(鉴别数据)(authentication data)
1H-NMR(δ,CDCl3) 1 H-NMR (δ, CDCl 3 )
3.41(1H,d,j=18.5),3.59(1H,d,j=18.5),4.92(1H,d,j=4.9),5.82(1H,d,d,j=4.9,9.3),6.12(1H,d,j=9.3),3.58(1H,d,j=16.1),3.67(1H,d,j=16.1),7.40~7.28(5H,m),4.39(1H,d,j=11.9),4.50(1H,d,j=11.9),5.20(2H,s),7.32(2H,d,j=8.6),6.88(2H,d,j=8.6),3.80(3H,s)3.41 (1H, d, j = 18.5), 3.59 (1H, d, j = 18.5), 4.92 (1H, d, j = 4.9), 5.82 (1H, d, d, j = 4.9, 9.3), 6.12 ( 1H, d, j = 9.3), 3.58 (1H, d, j = 16.1), 3.67 (1H, d, j = 16.1), 7.40 ~ 7.28 (5H, m), 4.39 (1H, d, j = 11.9) , 4.50 (1H, d, j = 11.9), 5.20 (2H, s), 7.32 (2H, d, j = 8.6), 6.88 (2H, d, j = 8.6), 3.80 (3H, s)
FT-IR(cm-1,KBr)FT-IR (cm -1 , KBr)
3449cm-1、3271cm-1、1778cm-1、1251cm-1 3449cm -1 , 3271cm -1 , 1778cm -1 , 1251cm -1
FAB-MSFAB-MS
M+1:487m/zM+1: 487m/z
另外,按照与实施例1同样的方法对由实施例4得到的3-氯甲基-3-头孢烯衍生物结晶进行X射线衍射分析,显示出与实施例1同样的X射线衍射图样。In addition, X-ray diffraction analysis was performed on the 3-chloromethyl-3-cephem derivative crystal obtained in Example 4 in the same manner as in Example 1, and the same X-ray diffraction pattern as in Example 1 was shown.
实施例5Example 5
将57.4g(0.052mol)含有57.6重量%的氯化吖丁啶酮衍生物(化合物(10))的二噁烷溶液加入到用氮气置换的滴液漏斗中,加入50g无水甲醇(关东化学试药)稀释作为A液。57.4 g (0.052 mol) of a dioxane solution containing 57.6% by weight of azetidinone derivatives (compound (10)) was added to a dropping funnel replaced with nitrogen, and 50 g of anhydrous methanol (Kanto Chemical Co., Ltd. Reagent) was diluted as solution A.
用67.0g无水甲醇稀释13.5g含有24重量%甲醇钠的甲醇溶液(试剂一级),配制成含有4重量%甲醇钠(0.060mol)的甲醇溶液,作为B液。Dilute 13.5 g of a methanol solution containing 24% by weight of sodium methoxide (reagent grade 1) with 67.0 g of anhydrous methanol to prepare a methanol solution containing 4% by weight of sodium methoxide (0.060 mol) as liquid B.
在用氮气置换的反应用烧瓶中加入12.9g二噁烷,加入160mL无水乙醇,冷却到-2~2℃。在加入了冷却的反应用溶剂的四口烧瓶中将全部上述A液加入到反应溶剂中(pH值4)。12.9 g of dioxane and 160 mL of absolute ethanol were added to a reaction flask replaced with nitrogen, and cooled to -2 to 2°C. In the four-neck flask added with the cooled reaction solvent, all the above liquid A was added to the reaction solvent (pH value 4).
然后,一边将反应体系的温度维持在-2~2℃之间,一边用约2小时滴加B液。当B液滴加了大约1/3后,反应液开始出现白色混浊,成为含有白色结晶的浆液。滴加结束时,pH值为8。滴加结束以后,再在0℃下搅拌0.25小时进行反应。Then, liquid B was added dropwise over about 2 hours while maintaining the temperature of the reaction system between -2°C and 2°C. When about 1/3 of the liquid B was added dropwise, the reaction liquid began to appear white turbid, and became a slurry containing white crystals. At the end of the addition, the pH was 8. After completion of the dropwise addition, the mixture was further stirred at 0° C. for 0.25 hours to perform a reaction.
反应结束以后,在反应结束后的反应液中添加0.40g醋酸进行中和。中和后反应体系的pH值为4~5。在中和处理后,再就这样在-2~2℃下搅拌0.5小时进行熟化。After the reaction was completed, 0.40 g of acetic acid was added to the reaction solution after the reaction for neutralization. The pH value of the reaction system after neutralization is 4-5. After the neutralization treatment, the mixture was further aged with stirring at -2 to 2°C for 0.5 hours.
然后,在熟化结束以后,用3G玻璃过滤器过滤,以18g用冰冷却的甲醇淋洗得到的滤饼,再用36g含水30%的甲醇溶液进行第二次淋洗,以18g用冰冷却的甲醇进行第三次淋洗。Then, after the aging is finished, filter with a 3G glass filter, rinse the obtained filter cake with 18g of ice-cooled methanol, then use 36g of 30% methanol solution containing water for the second rinse, and rinse with 18g of ice-cooled methanol. Methanol for the third rinse.
将经过洗涤处理的滤饼放入干燥器中,在室温下放置一夜,用真空泵干燥,得到20.50g的3-氯甲基-3-头孢烯衍生物结晶(通式(2a))(纯度92.0%,收率74.5%)。Put the washed filter cake into a desiccator, place it overnight at room temperature, and dry it with a vacuum pump to obtain 20.50 g of 3-chloromethyl-3-cephem derivative crystals (general formula (2a)) (purity 92.0 %, yield 74.5%).
(鉴别数据)(authentication data)
1H-NMR(δ,CDCl3) 1 H-NMR (δ, CDCl 3 )
3.41(1H,d,j=18.5),3.59(1H,d,j=18.5),4.92(1H,d,j=4.9),5.82(1H,d,d,j=4.9,9.3),6.12(1H,d,j=9.3),3.58(1H,d,j=16.1),3.67(1H,d,j=16.1),7.40~7.28(5H,m),4.39(1H,d,j=11.9),4.50(1H,d,j=11.9),5.20(2H,s),7.32(2H,d,j=8.6),6.88(2H,d,j=8.6),3.80(3H,s)3.41 (1H, d, j = 18.5), 3.59 (1H, d, j = 18.5), 4.92 (1H, d, j = 4.9), 5.82 (1H, d, d, j = 4.9, 9.3), 6.12 ( 1H, d, j = 9.3), 3.58 (1H, d, j = 16.1), 3.67 (1H, d, j = 16.1), 7.40 ~ 7.28 (5H, m), 4.39 (1H, d, j = 11.9) , 4.50 (1H, d, j = 11.9), 5.20 (2H, s), 7.32 (2H, d, j = 8.6), 6.88 (2H, d, j = 8.6), 3.80 (3H, s)
FT-IR(cm-1,KBr)FT-IR (cm -1 , KBr)
3449cm-1、3271cm-1、1778cm-1、1251cm-1 3449cm -1 , 3271cm -1 , 1778cm -1 , 1251cm -1
FAB-MSFAB-MS
M+1:487m/zM+1: 487m/z
比较例1Comparative example 1
将65.8g(0.052mol)含有49.7重量%的氯化吖丁啶酮衍生物(化合物(10))的二噁烷溶液加入到用氮气置换的滴液漏斗中,加入50g无水甲醇(关东化学试药)进行稀释作为A液。65.8 g (0.052 mol) of a dioxane solution containing 49.7% by weight of azetidinone derivatives (compound (10)) was added to a dropping funnel replaced with nitrogen, and 50 g of anhydrous methanol (Kanto Chemical Co., Ltd. Reagent) was diluted as solution A.
用85.0g无水甲醇稀释17.0g含有24重量%甲醇钠的甲醇溶液(试剂一级),配制成含有4重量%甲醇钠(0.076mol)的甲醇溶液,作为B液。Dilute 17.0 g of a methanol solution containing 24% by weight sodium methoxide (reagent grade 1) with 85.0 g of anhydrous methanol to prepare a methanol solution containing 4% by weight of sodium methoxide (0.076 mol) as liquid B.
在反应用烧瓶中加入13g二噁烷,加入160mL无水乙醇,冷却到-2~2℃。在加入有冷却的反应溶剂的四口烧瓶中将上述A液总量的1/8加入到上述配制好的反应溶剂中(pH值4)。Add 13 g of dioxane to the reaction flask, add 160 mL of absolute ethanol, and cool to -2 to 2°C. Add 1/8 of the total amount of the above liquid A into the prepared reaction solvent (pH 4) in the four-necked flask with cooled reaction solvent.
然后,一边将反应体系的温度维持在-2~2℃之间,一边同时滴加A液和B液。当B液滴加了大约1/5后,反应液开始出现白色混浊,成为含有白色结晶的浆液。然后同时滴加A液和B液,继续滴加大约4小时,到A液滴加完毕(pH值是7~8)。此时B液的滴加量是80.4g,pH值是7~8。需要30分钟再将剩余的总量20g的B液滴加。此时的反应液是带有红色的褐色。结束滴加时的pH值为10。再在0℃下搅拌0.25小时进行反应。Then, liquid A and liquid B were simultaneously added dropwise while maintaining the temperature of the reaction system between -2°C and 2°C. When about 1/5 of the liquid B was added dropwise, the reaction liquid began to appear white turbid, and became a slurry containing white crystals. Then add liquid A and liquid B dropwise at the same time, and continue to add dropwise for about 4 hours until the dropwise addition of liquid A is completed (pH value is 7-8). At this time, the amount of liquid B added dropwise was 80.4 g, and the pH value was 7-8. It takes 30 minutes to add the remaining 20 g of liquid B dropwise. The reaction liquid at this time was reddish brown. The pH at the end of the dropwise addition was 10. The reaction was further stirred at 0°C for 0.25 hours.
反应结束以后,在反应结束后的反应液中添加0.64g醋酸进行中和。中和后反应体系的pH值为4~5。在中和处理后,再就这样在-2~2℃下搅拌0.5小时进行熟化。After the reaction was completed, 0.64 g of acetic acid was added to the reaction solution after the reaction for neutralization. The pH value of the reaction system after neutralization is 4-5. After the neutralization treatment, the mixture was further aged with stirring at -2 to 2°C for 0.5 hours.
然后,在熟化结束以后,用3G玻璃过滤器过滤,以18g用冰冷却的甲醇淋洗得到的滤饼,再用36g含水30%的甲醇溶液进行第二次淋洗,以18g用冰冷却的甲醇进行第三次淋洗。Then, after the aging is finished, filter with a 3G glass filter, rinse the obtained filter cake with 18g of ice-cooled methanol, then use 36g of 30% methanol solution containing water for the second rinse, and rinse with 18g of ice-cooled methanol. Methanol for the third rinse.
将经过洗涤处理的滤饼放入干燥器中,在室温下放置一夜,用真空泵干燥,得到18.07g的3-氯甲基-3-头孢烯衍生物结晶(通式(2a))(纯度85.9%,收率61.3%)。The washed filter cake is put into a desiccator, placed overnight at room temperature, and dried with a vacuum pump to obtain 18.07g of 3-chloromethyl-3-cephem derivative crystals (general formula (2a)) (purity 85.9 %, yield 61.3%).
比较例2Comparative example 2
在氮气环境下将71.48g(0.104mol)的氯化吖丁啶酮衍生物(化合物(10))溶解于640mL无水DMF中,冷却到-30℃。然后在-30~-20℃下每次很少量地滴加28%17.76g氨水(0.292mol,相当于2.8倍mol)。滴加后在-30~-20℃下熟化1小时。Under a nitrogen atmosphere, 71.48 g (0.104 mol) of the azetidinone chloride derivative (compound (10)) was dissolved in 640 mL of anhydrous DMF, and cooled to -30°C. Then, 28% 17.76 g of ammonia water (0.292 mol, equivalent to 2.8 times mol) was added dropwise in small amounts at a time at -30 to -20°C. After dropping, mature at -30~-20°C for 1 hour.
反应结束后,在反应液中加入5%的盐酸,将pH值调节到4~5,然后再加入1.92L醋酸,在0℃下分离有机层。然后用饱和食盐水洗涤分离出的有机层两次,然后,在有机层中加入无水硫酸钠进行脱水。After the reaction, 5% hydrochloric acid was added to the reaction solution to adjust the pH value to 4-5, and then 1.92L acetic acid was added, and the organic layer was separated at 0°C. Then, the separated organic layer was washed twice with saturated brine, and anhydrous sodium sulfate was added to the organic layer for dehydration.
然后在减压下浓缩该脱水后的有机层,得到38.0g(纯度93.3%,收率70.0%)油状的3-氯甲基-3-头孢烯衍生物(通式(2a))。Then, the dehydrated organic layer was concentrated under reduced pressure to obtain 38.0 g (purity 93.3%, yield 70.0%) of an oily 3-chloromethyl-3-cephem derivative (general formula (2a)).
(鉴别数据)(authentication data)
1H-NMR(δ,CDCl3) 1 H-NMR (δ, CDCl 3 )
3.41(1H,d,j=18.5),3.59(1H,d,j=18.5),4.92(1H,d,j=4.9),5.82(1H,d,d,j=4.9,9.3),6.12(1H,d,j=9.3),3.58(1H,d,j=16.1),3.67(1H,d,j=16.1),7.40~7.28(5H,m),4.39(1H,d,j=11.9),4.50(1H,d,j=11.9),5.20(2H,s),7.32(2H,d,j=8.6),6.88(2H,d,j=8.6),3.80(3H,s)3.41 (1H, d, j = 18.5), 3.59 (1H, d, j = 18.5), 4.92 (1H, d, j = 4.9), 5.82 (1H, d, d, j = 4.9, 9.3), 6.12 ( 1H, d, j = 9.3), 3.58 (1H, d, j = 16.1), 3.67 (1H, d, j = 16.1), 7.40 ~ 7.28 (5H, m), 4.39 (1H, d, j = 11.9) , 4.50 (1H, d, j = 11.9), 5.20 (2H, s), 7.32 (2H, d, j = 8.6), 6.88 (2H, d, j = 8.6), 3.80 (3H, s)
FT-IR(cm-1,KBr)FT-IR (cm -1 , KBr)
3449cm-1、3271cm-1、1778cm-1、1251cm-1 3449cm -1 , 3271cm -1 , 1778cm -1 , 1251cm -1
FAB-MSFAB-MS
M+1:487m/zM+1: 487m/z
比较例3Comparative example 3
将10.0g由比较例2得到的3-氯甲基-3-头孢烯衍生物(通式(2a))溶解于28mL无水DMF中。10.0 g of the 3-chloromethyl-3-cephem derivative (general formula (2a)) obtained in Comparative Example 2 was dissolved in 28 mL of anhydrous DMF.
另外在3℃下配制400mL的冷却的甲醇,在3~5℃的温度下在此冷却的甲醇中缓慢滴加上述溶解有油状3-氯甲基-3-头孢烯衍生物的DMF溶液,析出3-氯甲基-3-头孢烯衍生物结晶。In addition, 400 mL of cooled methanol was prepared at 3°C, and the DMF solution in which the oily 3-chloromethyl-3-cephem derivative was dissolved was slowly added dropwise at a temperature of 3 to 5°C to precipitate 3-Chloromethyl-3-cephem derivative crystallization.
固液分离后,用甲醇淋洗回收的3-氯甲基-3-头孢烯衍生物结晶,然后在减压下干燥,得到8.62g(纯度94.0%,收率86.2%,由比较例2求得的收率是60.3%)3-氯甲基-3-头孢烯衍生物结晶。After solid-liquid separation, the crystallization of 3-chloromethyl-3-cephem derivatives reclaimed by methanol rinse, then dry under reduced pressure, obtain 8.62g (purity 94.0%, yield 86.2%, obtain by comparative example 2 The yield obtained was 60.3%) of 3-chloromethyl-3-cephem derivative crystals.
(鉴别数据)(authentication data)
1H-NMR(δ,CDCl3) 1 H-NMR (δ, CDCl 3 )
3.41(1H,d,j=18.5),3.59(1H,d,j=18.5),4.92(1H,d,j=4.9),5.82(1H,d,d,j=4.9,9.3),6.12(1H,d,j=9.3),3.58(1H,d,j=16.1),3.67(1H,d,j=16.1),7.40~7.28(5H,m),4.39(1H,d,j=11.9),4.50(1H,d,j=11.9),5.20(2H,s),7.32(2H,d,j=8.6),6.88(2H,d,j=8.6),3.80(3H,s)3.41 (1H, d, j = 18.5), 3.59 (1H, d, j = 18.5), 4.92 (1H, d, j = 4.9), 5.82 (1H, d, d, j = 4.9, 9.3), 6.12 ( 1H, d, j = 9.3), 3.58 (1H, d, j = 16.1), 3.67 (1H, d, j = 16.1), 7.40 ~ 7.28 (5H, m), 4.39 (1H, d, j = 11.9) , 4.50 (1H, d, j = 11.9), 5.20 (2H, s), 7.32 (2H, d, j = 8.6), 6.88 (2H, d, j = 8.6), 3.80 (3H, s)
FT-IR(cm-1,KBr)FT-IR (cm -1 , KBr)
3449cm-1、3271cm-1、1778cm-1、1251cm-1 3449cm -1 , 3271cm -1 , 1778cm -1 , 1251cm -1
FAB-MSFAB-MS
M+1:487m/zM+1: 487m/z
然后,按照与实施例1相同的方法对由比较例3得到的3-氯甲基-3-头孢烯衍生物结晶进行X射线衍射分析,其X射线衍射图样示于表2中。Then, X-ray diffraction analysis was performed on the 3-chloromethyl-3-cephem derivative crystal obtained in Comparative Example 3 in the same manner as in Example 1, and its X-ray diffraction pattern is shown in Table 2.
表2
(注)表2中的d是晶格面间距;I/I0是相对于d=4.17衍射峰的相对强度。(Note) d in Table 2 is the spacing between lattice planes; I/I 0 is the relative intensity of the diffraction peak with respect to d=4.17.
比较例4Comparative example 4
在氮气环境下将35.74g(0.052mol)的氯化吖丁啶酮衍生物(化合物(10))在135g甲醇中稀释,并冷却到-5℃。然后在-5~-2℃下,用30分钟,每次少量地将35.0g(0.078mol,1.5倍mol)含有12.5%苛性钾的20%含水乙醇的溶液滴加。滴加后在-2~0℃下熟化1小时。熟化后的pH值是9。熟化完成以后,加入醋酸将pH值调节到4~5,然后就这样在-2~2℃下搅拌0.5小时进行熟化。然后在熟化完成以后,用3G玻璃漏斗过滤,以18g用冰冷却的甲醇淋洗得到的滤饼,再用36g含水30%的甲醇进行第二次淋洗,用冰冷却的甲醇进行第三次淋洗。将经过洗涤处理的滤饼放入干燥器中,在室温下放置一夜,用真空泵干燥,得到15.15g(纯度51.3%,收率30.7%)的黄褐色的3-氯甲基-3-头孢烯衍生物(通式(2a))结晶。35.74 g (0.052 mol) of the chlorinated azetidinone derivative (compound (10)) was diluted in 135 g of methanol under nitrogen atmosphere and cooled to -5°C. Then, at -5 to -2°C, add dropwise a solution of 35.0 g (0.078 mol, 1.5 times mol) of 20% aqueous ethanol containing 12.5% caustic potash in 30 minutes. After the dropwise addition, it was matured at -2 to 0°C for 1 hour. The pH value after ripening is 9. After aging is completed, acetic acid is added to adjust the pH value to 4-5, and then aged at -2-2°C for 0.5 hours with stirring. Then, after the aging is completed, filter with a 3G glass funnel, rinse the obtained filter cake with 18 g of ice-cooled methanol, then use 36 g of 30% water-containing methanol for the second rinse, and use ice-cooled methanol for the third time. Rinse. Put the washed filter cake into a desiccator, place it overnight at room temperature, and dry it with a vacuum pump to obtain 15.15 g (purity 51.3%, yield 30.7%) of tan 3-chloromethyl-3-cephem The derivative (general formula (2a)) crystallizes.
<稳定性试验><Stability Test>
将由实施例1~5和比较例1~4得到的3-氯甲基-3头孢烯衍生物各5g放入密闭的烧杯中,在温度设定为25℃的恒温室里放置30天。5 g each of the 3-chloromethyl-3 cephem derivatives obtained in Examples 1 to 5 and Comparative Examples 1 to 4 were put into a closed beaker, and placed in a thermostatic chamber set at 25° C. for 30 days.
在放置30天以后再对各个3-氯甲基-3-头孢烯衍生物进行纯度测定,其结果如在表3中所示。The purity of each 3-chloromethyl-3-cephem derivative was measured after standing for 30 days, and the results are shown in Table 3.
表3
发明的效果The effect of the invention
由上述结果可以看出,按照本发明的制造方法,能够通过在工业上有利的方法,不间断地以高收率和高纯度制造出可用作头孢菌素系的各种抗菌素的合成中间体的3-氯甲基-3-头孢烯衍生物结晶。而且由本发明的制造方法得到的3-氯甲基-3-头孢烯衍生物结晶在温和的条件下具有优异的长期稳定性。From the above results, it can be seen that according to the production method of the present invention, synthetic intermediates usable as various antibiotics of the cephalosporin series can be produced continuously with high yield and high purity by an industrially advantageous method Crystallization of 3-chloromethyl-3-cephem derivatives. Furthermore, the 3-chloromethyl-3-cephem derivative crystal obtained by the production method of the present invention has excellent long-term stability under mild conditions.
Claims (14)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03149608 CN1580058A (en) | 2003-08-01 | 2003-08-01 | Method for preparig 3-chloromethyl-3-cephem derivative crystalline |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03149608 CN1580058A (en) | 2003-08-01 | 2003-08-01 | Method for preparig 3-chloromethyl-3-cephem derivative crystalline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1580058A true CN1580058A (en) | 2005-02-16 |
Family
ID=34579602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03149608 Withdrawn CN1580058A (en) | 2003-08-01 | 2003-08-01 | Method for preparig 3-chloromethyl-3-cephem derivative crystalline |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1580058A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009129662A1 (en) * | 2008-04-21 | 2009-10-29 | 湖南有色凯铂生物药业有限公司 | Process for preparation of 7-phenylacetamido-3-chloromethyl-3-cephem-4- carboxylic acid p-methoxybenzyl ester |
| CN101525340B (en) * | 2008-03-04 | 2011-05-18 | 山东方兴科技开发有限公司 | Method for synthesizing 7-phenylacetylamino-3-chloromethyl cephalosporin alkyl acid p-methoxybenzyl ester |
-
2003
- 2003-08-01 CN CN 03149608 patent/CN1580058A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101525340B (en) * | 2008-03-04 | 2011-05-18 | 山东方兴科技开发有限公司 | Method for synthesizing 7-phenylacetylamino-3-chloromethyl cephalosporin alkyl acid p-methoxybenzyl ester |
| WO2009129662A1 (en) * | 2008-04-21 | 2009-10-29 | 湖南有色凯铂生物药业有限公司 | Process for preparation of 7-phenylacetamido-3-chloromethyl-3-cephem-4- carboxylic acid p-methoxybenzyl ester |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1968927A (en) | Enantioselektive preparation of quinoline derivative | |
| CN1243755C (en) | Coupling methods and intermediates for the preparation of cephalosporins | |
| CN101065379A (en) | Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones | |
| CN1628087A (en) | Production of alkenones | |
| CN1107679C (en) | Selective production method of Z isomer of 3-(2-substituted-vinyl) cephalosporin | |
| CN86100852A (en) | Mould poison nuclear (Cephem) derivative of cephalo and intermediates preparation thereof | |
| CN101052633A (en) | Methods of preparing indazole compounds | |
| CN1863808A (en) | Penam crystal and process for producing the same | |
| CN1639096A (en) | Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative | |
| CN1184109A (en) | Enantiomerically pure cycloalkanol indole carboxylic acid, azaindole carboxylic acid, pyrimido[1,2-a]-indole carboxylic acid and their active derivatives | |
| CN1671669A (en) | Synthesis of diaryl pyrazoles | |
| CN1282652C (en) | Method for producing 3-chloromethyl-3-cephem derivative crystal | |
| CN1042536C (en) | Method for preparing cephalosporin antibiotics with thiazolyl intermediate cis-isomer | |
| CN1059438C (en) | Method for preparing cynnematin antibiotic | |
| CN1243756C (en) | Process and ester derivatives for preparing cephalosporins | |
| CN1580058A (en) | Method for preparig 3-chloromethyl-3-cephem derivative crystalline | |
| CN1057297C (en) | Crystals of antimicrobial compound | |
| CN1537109A (en) | Novel modifications of the trometamol salt of R-lipoic acid and process for preparing them | |
| CN1922193A (en) | Chemical process | |
| CN1849324A (en) | Process for producing 3-chloromethyl-3-cephem derivative | |
| CN1044280A (en) | Cephalosporin derivatives and preparation method thereof | |
| CN1310893C (en) | Condensation reagent and its preparation method | |
| CN1031534A (en) | The method for preparing 3-hanging methylene cephalosporin derivatives | |
| CN1620425A (en) | Method for preparing 2-(substituted phenyl)-2-hydroxyl-ethyl carbamate | |
| CN1578760A (en) | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C04 | Withdrawal of patent application after publication (patent law 2001) | ||
| WW01 | Invention patent application withdrawn after publication |